Assessment of collaterals in acute ischaemic stroke using CT imaging techniques by Guarisco, Marta
 
 
 
 
 
 
 
 
Guarisco, Marta (2020) Assessment of collaterals in acute ischaemic stroke 
using CT imaging techniques. MSc(R) thesis. 
 
 
 
https://theses.gla.ac.uk/80277/ 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
ASSESSMENT OF COLLATERALS IN
ACUTE ISCHAEMIC STROKE USING
CT IMAGING TECHNIQUES
Marta Guarisco
Submitted in partial fulfillment of the requirements for the
Degree of Master of Science by Research
Institute of Neuroscience and Psychology
College of Medical, Veterinary and Life Sciences
University of Glasgow
March 2020
Contents
Abstract iii
List of tables iv
List of figures vi
Author’s declaration viii
Abbreviations ix
1 Introduction 1
1.1 Collaterals in acute ischaemic stroke . . . . . . . . . . . . . . . . . 1
1.2 Assessment of collaterals with CT imaging techniques . . . . . . . . 4
1.3 Thesis objectives and contents . . . . . . . . . . . . . . . . . . . . . 5
1.4 Overview of scales used in Stroke . . . . . . . . . . . . . . . . . . . 6
2 Systematic literature review of methods for assessing collateral
flow 9
2.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
2.1.1 Leptomeningeal collaterals . . . . . . . . . . . . . . . . . . . 12
2.2 Materials and methods . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.2.1 Search strategy . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.2.2 Data extraction . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.3.1 Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
2.3.2 Collaterals assessment with catheter angiography . . . . . . 19
i
CONTENTS
2.3.3 Collaterals assessment with computed tomography . . . . . . 30
2.3.4 Collaterals assessment with magnetic resonance imaging . . 46
2.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
3 Quality of collateral scores on single-phase CTA 59
3.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
3.1.1 Clinical trials . . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.2 Materials and methods . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.2.1 Site of occlusion . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.2.2 Assessment of collaterals on single phase CTA . . . . . . . . 63
3.2.3 Assessment of collaterals on tMIP from CTP . . . . . . . . . 63
3.2.4 Phase of acquisition of CTA scans . . . . . . . . . . . . . . . 64
3.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
3.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
4 Conclusions 71
A Search strategy 73
B 3D Slicer Module 79
Bibliography 143
ii
Abstract
There is growing evidence that the degree of collateral circulation in acute ischaemic
stroke, and in particular of leptomeningeal collaterals, is a useful imaging marker
that is correlated with various baseline and outcome clinical parameters. However,
methods for assessing collaterals on acute ischaemic stroke are poorly standardized
at present.
In the first part of this master thesis, an in-depth systematic review of methods
for assessing collaterals published between 2009 and 2017 is presented. The review
shows that although DSA is still used as gold standard, there has been a shift
towards CT- and MR- based imaging modalities, which offer equal or higher
sensitivity while being at the same time less invasive for the patient. In particular,
CT seems to be a good candidate for replacing DSA as gold standard in the future
and one scoring method proposed by Tan et al. has been widely adopted in recent
studies. However, there has been zero or minimal progress towards a standardized
method since previously published reviews.
In the second part of this thesis, a retrospective study conducted at the QEUH
(Glasgow) to assess the reliability of collaterals on single-phase CTA is presented.
CTA does not provide time-resolved information and this may lead to mislabeling
of collaterals. The phase of acquisition of the scan should be taken into account
when evaluating collaterals. From 4 past clinical trials, we identified patients with
confirmed ICA or MCA occlusion. Three temporal-MIP images were reconstructed
from CTP for each patient, each image corresponding to one of arterial, equilibrium
and venous phase of contrast enhancement. Collateral scores were measured on both
the temporal-MIP images and on single-phase CTA angiography and it was found
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that there was substantial agreement between the scores if the CTA was acquired in
the equilibrium phase but only moderate agreement if the CTA was acquired in the
arterial or venous phase. This confirms that the arterial phase, despite being the
preferred phase for assessing arterial occlusion and recanalization, is not the best
phase for assessing collaterals and that a combination of CTA-CTP or a CTA scan
employing a time-resolved protocol should be employed when evaluating collateral
status in stroke patients.
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Chapter 1
Introduction
1.1 Collaterals in acute ischaemic stroke
Stroke is a clinical syndrome given by an acute focal neurological deficit arising
from a vascular problem. With about five and half million of deaths per year [8],
stroke is the second leading cause of death worldwide [9] and the fourth in the UK
(third in Scotland) [10].
Ischaemia is responsible for about 85% of all strokes in the UK [11]. Ischaemia
is generally induced by a transient or permanent occlusion of a cerebral artery.
The occlusion can be caused by a thrombus or embolus and can compromise the
supply of a normal cerebral blood flow in the territory supplied by the affected
vessel.
The phrase “time is brain” emphasizes the rapidity with which neurons are lost in
the acute phase of ischaemic stroke, which is estimated to be around 1.9 million
neurons/minute [12]. Due to the high demand for oxygen and glucose of cerebral
tissues, a severe flow reduction quickly results into neurological death [13]. Normal
cerebral blood flow (CBF) is around 50 to 60 mL/100 g tissue/min [14, 15]. If
it drops under 10 mL/100g tissue/min, almost immediate damage is observed
and infarcted tissue can appear within minutes. However, a reduced flow of 10-
1
1.1 Collaterals in acute ischaemic stroke
20 mL/100g tissue/min has been shown to be sufficient to keep most neurons
structurally intact, though not functional, for a limited period of time [15]. In the
core of the ischaemic territory during acute stroke blood flow is often reduced to
below 4-10% of normal levels. Thus, the core undergoes irreversible damage in the
absence of prompt and adequate reperfusion. In the peripheral zones, instead, there
is usually a certain amount of ischaemic but non infarcted tissue that is supported
by collateral circulation and is potentially salvageable. This territory is commonly
referred to as the ischaemic penumbra and its fate is determined by several factors,
including the degree of ischemia and timing of reperfusion.
The main strategy for treating acute ischaemic stroke is revascularization, which
is normally obtained via long-established intravenous thrombolysis (IVT) thera-
pies with alteplase or more recent endovascular treatments such as intra-arterial
thrombolysis and mechanical thrombectomy [16]. However, all the therapies so far
available present different types of contraindications and are characterized by a loss
of efficacy over time [17]. Administration of intravenous thrombolysis, for example,
is recommended only up to 4.5 hours from symptoms onset and even with this
precautionary requirement it does not always lead to successful revascularization
and reperfusion [18, 19]. In their recent study, Bivard et al. showed that different
factors, such as long onset to imaging time, large ischaemic core and lesion volume
and symptomatic intracranial hemorrhage, are highly predictive of unacceptably
poor outcome of thrombolysis treatment [19]. On the other hand recent trials
have demonstrated the benefits of endovascular intra-arterial therapies (IAT) if
performed within 6 hours from symptoms onset [16, 20]. In particular, the MR
CLEAN study has shown improved clinical outcome of intra-arterial reperfusion
therapies (IART) compared to the best medical care [21]. But IAT also has some
pitfalls, such as the risk of complications secondary to endovascular manipula-
tion [22]. Moreover, successful reperfusion following IAT might not automatically
translate into improved outcome [23]. The risk of complications should always be
balanced against the potential benefit on an individual case basis.
The best approach to endovascular treatment, including patient selection strategies,
optimum device selection and outcome definitions are still being debated [24].
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The availability of different therapeutic options makes it necessary to develop
validated methods to help identifying when intravenous thrombolysis is likely to be
futile but patients might benefit from newer more efficient treatments. When making
decisions in acute ischaemic stroke (AIS) settings, clinicians have traditionally relied
on clinical data such as the baseline National Institutes of Health Stroke Scale
(NIHSS) score and time of symptoms onset. However, modern imaging technology
now allows the inspection of extracranial arteries, extent of ischaemia and extent
of infarcted core and penumbra, among other things. It is thus desirable to define
imaging protocols which allow to evaluate neuroimaging markers with promptness,
convenience, consistency and accuracy for diagnosis and prognosis in the acute
stroke.
The extension of good collateral flow (CF) has been recently demonstrated to be
an independent predictor of clinical outcome in acute ischaemic stroke [25, 26, 27].
Being often the only blood supply available to ischaemic territories, CF can be
responsible for keeping the penumbra viable for a variable period of time. In
particular, leptomeningeal (LM) collaterals have been shown to contribute to early
neurological improvement (ENI) after stroke. Thus the signs of development of
collateral on clinical images in the acute setting can help identify patients more
likely to show ENI and be used to select patients for endovascular therapy [28].
Unfortunately there is not at present an optimal method for assessing collateral flow.
The many grading systems reported in literature are poorly agreed [29] and they
all require the subjective scoring by an experienced radiologist or stroke physician,
which often results in a poor inter-observer agreement. Most of the proposed
methods are restricted to the analysis of specific vessels or vascular territories. The
majority of collaterals scoring system relies on time-consuming procedures and is
therefore unsuitable for use in the clinical practice where time is critical.
There is a need to provide a collaterals scoring method that is, firstly, standardized
and, secondly, automated, so as to enable a faster, more objective and more reliable
assessment of collaterals in acute stroke decision making.
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1.2 Assessment of collaterals with CT imaging
techniques
Non-contrast computed tomography (CT) is the most widely available and used
imaging modality for stroke patients because it is relatively fast to perform and
allows to detect early ischaemic changes such a hypoattenuation, focal swelling and
intracerebral haemorrhage [30]. However, non-contrast CT provides limited resolu-
tion in terms of vessel detection and is not suitable for assessing collaterals.
CT angiography (CTA) combines CT with an injection of contrast medium in the
patient’s circulatory system, therefore producing scans with enhanced blood vessels.
CTA is also widely available in stroke centers, mostly due to the fact that it can be
performed in combination with a CT scans without moving the patient and with
minimal extra time [31].
CTA is normally performed with a volumetric helical scanner. A contrast medium
is injected in the patient’s circulatory system and the acquisition is timed such
that the imaging either starts at a fixed time interval after the delivery of the bolus
of contrast medium or is automatically triggered when the contrast concentration
within a ROI reaches a pre-specified threshold. The ROI is generally centered
around a point located in the ascending aorta.
One factor to keep in mind when performing CTA, is the phase of the scan. Once
injected, the contrast medium is pumped into the circulatory system and flows
through the arterial and venous apparatus. Depending on the starting time of
acquisition, a CTA scan may be acquired in an arterial, a venous or an intermediate
equilibrium phase wherein the amount of contrast in the arterial and venous vessels
is comparable.
It is important in CTA that the scanning is performed while the vascular territory
of interest exhibits the maximum enhancement. Often, CTA is performed in stroke
patients to identify occlusions in major arterial branches or to assess reperfusion
following thrombolytic therapy or thrombectomy and therefore it is configured to
capture the arterial phase of the bolus flow cycle. However, some suggested that
4
1.3 Thesis objectives and contents
since collaterals are measured in the affected hemisphere where it will be normal
to have a slowed flow, they may be better assessed in the late venous phase, after
the normal circulation is already washed out in the contralesional hemisphere [32].
A CTA scan acquired in an early arterial phase may show poor collaterals simply
because the contrast medium has not reached the territory of interested yet.
Time-resolved imaging techniques enable analysis of the vasculature at multiple
phases of contrast enhancement and therefore reduce the risk of mislabeling collat-
erals. Examples of time-resolved CT imaging techniques include multiphase CT
angiography (mpCTA) and CT perfusion (CTP). Multiphase CTA is a variant
of conventional CTA (hereinafter sometimes referred to as single-phase CTA or
spCTA as opposed to mpCTA) in which three time-resolved three-dimensional
images of the cerebral vasculature are provided. Each image captures a different
phase of contrast enhancement: peak arterial phase, equilibrium/peak venous phase
and late venous phase [33]. CT perfusion is a functional imaging technique which
provides quantitative temporal information by acquiring multiple brain images
in fast succession. The volume of interest is scanned repeatedly as the contrast
medium flows through the vasculature thereby providing time resolved information
about blood flow which can be used to reconstruct different types of perfusion
maps. CTP clearly provide the most complete information however it requires
post-processing and its interpretation is not as well understood as CT angiography.
In contrast, CTA provides a fast and relatively easy to implement protocol but
does not provide the temporal resolution of CTP and does not provide functional
information.
1.3 Thesis objectives and contents
The Queen Elizabeth University Hospital (QEUH) is one of the main stroke centers
in Scotland. At present, all patients arriving at the QEUH with suspected ischaemic
stroke undergo CT examination and in some cases CTA, however time-resolved CT
imaging or other time-resolved imaging are not included in the standard baseline
assessment of stroke patients. Moreover, although collateral parameters have been
5
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included in past research trials [34], they are not currently taken in consideration
in the daily practice for the diagnosis/prognosis of stroke patients.
It would be desirable to provide a reliable tool for measuring collaterals, for use
in the first instance in research trials but potentially also for future use in the
daily clinical practice. However, there are two main hurdles to this task: the first
one is that there isn’t a standardized method for assessing collaterals. The second
one is that at present time-resolved imaging is not part of the routine baseline
triage/diagnosis of stroke patients at the QEUH and as seen above the phase of
acquisition of CTA can play an important role in the assessment of collaterals.
Therefore the main objective of this thesis are:
• to conduct a systematic review of methods for assessing collateral vessels in
acute ischaemic stroke;
• to evaluate the reliability of collaterals measured on single-phase CT angiog-
raphy.
The remaining of this chapter is a brief overview of some scales used for assessing
the clinical symptoms and outcome of patients affected by AIS which are mentioned
in the following chapters. The second chapter is a systematic literature review of
methods for assessing collaterals in AIS. The third chapter reports the methods
and results of a retrospective study conducted by some members of the stroke
team at the QEUH in order to assess the relation between collaterals measured in
single-phase CTA and collaterals measure on MIP constructed from CT perfusion
(CTP). The last chapter is a short commentary on the conclusions of this thesis
and future work.
1.4 Overview of scales used in Stroke
This section is a very brief overview of some scales commonly used in the clinical
practice in the assessment of stroke patients and to which reference will be made
in the following chapters. More details on each scale are widely available in
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literature.
The National Institute of Health Score (NIHSS) is the most commonly used baseline
parameter to objectively quantify the impairment caused by a stroke. It comprises
11 grades that can be summarized as follows:
• 0: no stroke symptoms
• 1-4: minor stroke
• 5-15: moderate stroke
• 6-20: moderate to severe stroke
• 21-42: severe stroke.
The modified Ranking Scale (mRS) is the most commonly used parameter for
assessing functional outcome and it relates to independence in the daily activities.
It is mostly commonly assessed at 3 months after the stroke episode and it comprises
6 grades which can be summarized as
• 0-2: independent
• 3-6: dependent.
The Alberta stroke program early CT Score (ASPECTS) is a 10-point quantitative
score measured on CT for middle cerebral artery stroke [35]. It is determined
by segmenting the middle cerebral artery territory in 10 predefined regions and
deducting 1 point from the initial score of 10 for each region involved. It is now
well established that ASPECTS scores correlated with functional outcome at 3
months. In particular score ≤ 7 have been shown to predict worse outcomes.
The thrombolysis in myocardial ischemia (TIMI) score is a 4-point system for
assessing vessel revascularization following arterial occlusion, each grade being
defined as follows [36]:
• 0: no recanalization
• 1: minimal recanalization
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• 2: partial recanalization
• 3: complete recanalization.
Lastly, the thrombolysis in cerebral ischemia (TICI) score is a 4-point system
analogous to TIMI for assessing reperfusion following arterial occlusion [37]. The
TICI scale is defined as follows:
• 0: no perfusion
• 1: penetration with minimal perfusion
• 2: partial perfusion
– 2A: only partial filling of the entire vascular territory
– 2B: complete filling of all the expected vascular territory but filling
slower than normal
• 3: complete perfusion.
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Chapter 2
Systematic literature review of
methods for assessing collateral
flow
2.1 Introduction
Collateral flow (CF) is the perfusion via alternative indirect pathways when the
principal circulation of anterograde flow fails. In the first hours of an ischaemic
stroke, collaterals can play a crucial role in determining the patient’s outcome.
The penumbral regions of the ischaemic territories are often supplied by a certain
amount of collateral vessels whose quality strongly influences the rate at which the
penumbra is converted into core. In presence of favorable collaterals, it is possible
that the penumbra changes at a very slow rate, allowing in general for better clinical
outcomes and for a potential extension of the therapeutical time-windows [25].
Many recent studies support the hypothesis of the aiding role of collaterals and
demonstrated a significant correlation with outcome parameters. Among others,
good collaterals have been linked to small-lesion volume on follow-up imaging and
a favorable clinical outcome [1, 27], better response to intravenous thrombolysis
[38] and reduced loss of penumbral tissue [39].
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(a) (b)
Figure 2.1: (a) Maximum intensity projection (MIP) magnetic resonance angiogram
(MRA) showing collateral flow through the circle of Willis in a patient with
right-sided ICA occlusions [4]. (b) Schematic representation of retrograde
collateral flow from the ophthalmic branch of the external carotid artery after
ICA occlusion [5], Copyright of Cambridge University Press 2016, reproduced
with permission of The Licensor through PLSclear.
Figure 2.2: Axial (left) and coronal (right) MIP computer tomography angiography
(CTA) showing leptomeningeal collateral blood flow from the posterior
cerebral artery (arrows) to distal segments of the occluded middle cerebral
artery [6].
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There can be different sources of CF and depending on the location of the occlusion
one or more of them may be recruited in acute ischaemic stroke. In a very basic
classification we can distinguish between three main types of collaterals [40]: primary
collaterals given by segments of the circle of Willis, large-artery communications
between the extracranial and intracranial circulations and secondary CF through
the leptomeningeal vessels. The circle of Willis (figure 2.1 (a)) consists of an
anastomotic network connecting arteries from the anterior and posterior circulation
as well as between the sides and therefore it represents a natural compensation
mechanism in the presence of an occlusion in one of the parent vessels [41]. However,
only ∼ 50% of the individuals have been estimated to have a normal or complete
configuration of the circle of Willis with both the posterior communicating arteries
(PCoA) and an anterior communicating artery (ACA) [42]. The presence of any
variant can compromise the ability of the circle of Willis to compensate for occluded
vessels. The second class of collaterals includes the ophthalmic artery and the many
branches that arise from the external carotid artery in the neck. These represent a
potential source of CF in case of an occlusion of the internal carotid artery (ICA)
[43] (figure 2.1 (b)). Finally, when primary CF flow through the circle of Willis or
other large arteries has been exhausted or is not possible, e.g. in distal intracranial
occlusions that are beyond the circle of Willis, leptomeningeal vessels might be
recruited (figure 2.2). These are direct arteriole to arteriole connections of about
50-400 µm in diameter that join the terminal cortical branches of major cerebral
arteries, such as ACA, middle cerebral artery (MCA) and posterior cerebral artery
(PCA) forming a dense and very variable network in the leptomeninges [44, 41, 45].
Leptomeningeal collaterals allow for blood flow in both directions depending on
the haemodynamic and metabolic need of the two territories that they connect and
thus represent an important route for CF during a vascular occlusion [44].
Depending on the site of occlusion different collateral routes are recruited. For
example in proximal ICA occlusion, i.e. occlusions which spare the carotid terminus,
the circle of Willis offers potential for antegrade collateralization through the
anterior and posterior communicating arteries, provided these are present and
patent [45]. Alternatively, anastomoses between the extracranial arteries (ECA)
and intracranial arteries can be recruited in proximal ICA occlusions, as mentioned
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above. If the occlusion involves the carotid terminus instead the main channel for
collateral supply, the circle of Willis, is cut off. In this case the ACA ipsilateral
to the occlusion, if patent, can fill antegradely from the contralateral side, but
there is no possibility of antegrade supply to the middle cerebral artery (MCA)
territory. Leptomeningeal collaterals are the only resource for supplying the MCA
territory through retrograde filling from the ipsilateral ACA or PCA. The same
applies for occlusions of the M1 segment of the MCA or more distal segments, in
which antegrade collateralization to the ischaemic territory is precluded. Quite
interestingly, it has been shown that for MCA occlusions where only retrograde
CF through leptomeningeal is possible, the more distal the MCA occlusion the
more favorable the patient outcome [46]. This might be due to M1 occlusions also
cutting out the lenticulostriate arteries, which are end arteries and thus can not be
reached by retrograde collateral flow.
2.1.1 Leptomeningeal collaterals
Leptomeningeal collaterals are particularly interesting for researchers because unlike
primary collaterals they are quite difficult to visualize and their properties are not
completely understood yet. Many different studies suggested that leptomeningeal
collateral flow (LMF) is highly predictive of better clinical and radiological outcomes
after either intravenous or endovascular treatment of acute ischaemic stroke (table
2.1). Bang et al. showed that the state of pretreatment collaterals has a great
impact on the recanalization rate after thrombolytic therapy. It was hypothesized
that good collateral blood flow might allow thrombolytics to attack the thrombus
from both sides. Moreover they showed that therapeutic revascularization did
not result in better clinical outcome in patients with poor LMF [47]. Song et al.
also showed that in patient with poor collaterals successful reperfusion was not
significantly associated with favorable outcome and they inferred that time interval
from imaging scan to reperfusion is particularly crucial in this group of patients.
In fact collaterals affect the rate of penumbra loss and a rapid reperfusion might
prove to be beneficial even in subjects with poor collaterals [48]. In another study,
Christoforidis et al. showed that poor pial collaterals are associated with higher
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incidence and size of hemorrhage following intra-arterial thrombolytic treatment
[49].
LMF is therefore regarded by many as a good neuroimaging marker for decision
making and collateral scores are being included in the imaging criteria for patient
selection in an increasing number of studies. In the MR CLEAN trial [21] CF was
the only imaging variable to significantly modify treatment response to endovascular
therapy and in the ESCAPE trial [50] of endovascular thrombectomy it was one
of the patient selection criteria. Moreover, recent findings on the role of CF in
maintaining the penumbra during acute ischaemic stroke suggest that collateral flow
enhancement might be considered as a therapeutic tool to support the reperfusion
therapies in the treatment of acute stroke [51].
Yet the use of leptomeningeal collateral scoring in clinical practice and research trials
is still very limited. We believe that one of the main limitations in the affirmation of
collaterals as imaging marker is the fact that despite its now established importance
there is not to date a standardized method for assessing LMF in acute stroke.
The great variability in number, size and location makes it difficult to obtain
consistent results from studies investigating the function of leptomeningeal vessels,
with most works conducted on animals or post mortem [40]. Moreover, assessment
of leptomeningeal vessels is not simple in humans since it can not rely on their
direct visualization. Such small vessels are very difficult to capture on image and
their assessment must rely on the indirect evaluation of the extent and rate of
back-filling of pial arteries receiving blood flow from LMF [52] or on inference
of their presence from surrogate markers such as modified blood flow velocity on
transcranial doppler (TCD) [53].
Two recent systematic reviews of LM collaterals scoring systems have highlighted
this issue [29] [54]. McVerry et al. [29] examined a total of 81 papers published up
to 2009 and found 63 different scoring methods: 41 based on conventional digital
subtraction angiography (DSA), 7 on computed tomography (CT), 9 on magnetic
resonance (MR) and 6 on transcranial doppler imaging, with only 8 publications
reporting inter- and/or intra-observer agreement. Martinon et al. [54] reported
results from 48 publications up to 2013 (15 based on DSA , 14 on CT, 12 on MRI
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Table 2.1: Main associations between collaterals and clinical outcome of acute stroke
patients as reported in literature.
Better LPM collaterals Poor LPM collaterals
Higher baseline ASPECTS score[55] Higher and larger incidence of haemorrhage
[46, 49]
Lower NIHSS score at presentation [27] Large admission lesion size on MR-DWI [56]
Less infarct growth [57, 58, 27] Infarct growth despite recanalization [57, 47]
Smaller final infarct volumes [59, 60, 61, 27] Poor clinical outcome despite recanalization
[57, 47, 62]
Improved patient outcomes
[59, 58, 60, 61, 46, 55, 27] Increased mortality [63, 64, 65]
Better recanalization [47] and
reperfusion [66] after IAT
and 3 on TCD) and concluded that at present dynamic CT angiography (CTA)
seems to be the most appropriate method for collaterals evaluations, although
MRI probably has a future due to its non-invasive quality, high sensitivity and
continuous development of new techniques.
These two reviews offer a comprehensive picture of the main approaches up to
2013. However, with the constant advancements of imaging technologies and the
new findings about the correlation of LMF with clinical outcome, we expected the
number of publications now available discussing LMF assessment, whether using
new or previously published scoring methods, to be significantly higher. We thus
decided to perform an analogous systematic review to include publications between
2009-2016.
2.2 Materials and methods
2.2.1 Search strategy
The review was conducted on the Ovid online portal searching the MEDLINE
database (with Revisions) from 1946 to April Week 2 2017 and the Embase database
from 1996 to 2017 week 17. The search strategy (see Appendix 1) was devised in
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order to match papers treating a combination of three macroareas: ischaemic stroke,
collateral circulation and imaging. The keywords were selected by consulting the
MeSH database and including all relevant synonyms.
All studies published in English, performed in adult humans and dated on or after
1 Jan 2009 were initially included . The target population included patients with
acute stroke (<24 h from onset) or patients with cerebrovascular disease who had
CF assessed at some point. Terms such as “pial/cortical anastomoses/collateral”
were considered synonyms of leptomeningeal collaterals. The final search strategy
was optimized to respect these inclusion criteria and run on MEDLINE and Embase
on 12/04/17. The publications found on Ovid were then filtered based on relevance
to the topic. In the first passage, the studies were discarded based on titles
alone. The remaining papers were then inspected for relevant abstracts Finally,
the last group of papers was filtered based on full-text review. Studies that did not
describe the imaging assessment method were excluded. All publications which only
evaluated primary collateral flow but not LMF (e.g. through the circle of Willis or
via the ophthalmic artery) were also excluded from the analysis. All publications
regarding Moyamoya disease were rejected since the leptomeningeal collateral flow
observed in this condition is considered different from collaterals in stroke for
development, recruitment and flow dynamics. Some additional publications were
included following inspection of citations of all relevant articles in the initial search.
Conference abstracts were not excluded a priori but eventually none was included
for lack of complete information on the assessment method.
2.2.2 Data extraction
For each study we recorded
• site of occlusion: (if applicable)
• imaging modality: DSA, CT, MRI, TCD
• assessment criteria
• grading scale: number and definition of grades (if applicable)
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• clinical setting: acute/non acute
• reliability: whether inter and intra-observer agreement was assessed
• prognostic value: correlation with outcome parameters.
Methods with similar imaging modalities but different grading scales were considered
as different scoring methods. The clinical setting was considered acute if collaterals
were assessed within 24 h from stroke/transient ischaemic attack (TIA) symptom
onset, whereas non-stroke studies (e.g. chronic cerebrovascular disease) or AIS cases
assessed >24 h from symptom onset were considered as non-acute. Papers stating
that two or more raters were reaching an agreement by consensus or that reported
independent scoring by two readers but did not indicate any inter-rater coefficient,
were considered as not having reliability assessed (NS=not-stated). In studies
with automated scoring methods reliability was marked as not applicable (NA).
Similarly, when the outcome was not assessed because the study was focused on
comparing different imaging modalities or on evaluating the correlation with other
imaging parameters, the prognostic value was marked as not applicable, whereas if
outcome was assessed but the correlation with collaterals was not indicated, it was
marked as not stated (NS).
2.3 Results
2.3.1 Overview
MEDLINE and EMBASE searches yielded 9264 and 16199 publications respectively,
for a total of 25463 publications. The results were imported in Endnote and after
automated filtering for duplicates, 18253 items were inspected for the systematic
review. After filtering titles, 1541 publications were retained for abstract review.
After filtering abstract, 1225 further publications were discarded and 316 kept for
full-text review. Among the discarded ones, 85 were excluded because they only
discussed primary collaterals, 11 because it was not possible to retrieve the full-text,
12 because they scored collaterals without describing the scoring method and the
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remaining ones because not relevant. After full-text inspection, 233 publications
were retained for analysis. In addition, 15 papers from bibliographies of relevant
publications were found to be relevant and included in the review. In total 248
papers and 93 different criteria for grading LMF were recorded (table 2.2).
Thirty-two of the publications discussed assessed collaterals on two (n=30) and three
(n=2) different imaging modalities (DSA, CT, MRI, TCD). Fifty-two publications
compared 2 or more assessment criteria/grading scales, either on the same imaging
modality or different imaging modalities. No PET/SPECT based methods were
recorded and only one TCD-based method was recorded, from a paper by Levi et
al. [53]. In principle the presence, responsiveness and capacity of collaterals can be
indirectly inferred also from flow or metabolic indices measured on PET/SPECT.
In practice, the search yielded very few studies using TCD/PET/SPECT for LM
assessment and none of these met the inclusion criteria apart from Levi’s paper.
TCD provides little information about CF and only at the circle of Willis. It is
well suited for identifying collateralization in MCA occlusions where blood flow
is diverted from the distal ICA to ACA. In this case there is usually a flow with
higher velocity in the ipsilateral ACA as compared with the contralateral ACA.
This difference can be measured on TCD and used as surrogate marker for presence
of good collaterals [53]. By using this methods, Levi showed that the presence of
ACA flow diversion (FD) detected on TCD is strongly associated with improved
LMC and independently associated with 24 h infarct volume and modified Rankin
Scale (mRS) at 3-months.
CT is the modality with the highest number of publications (n=128) and dif-
ferent methods (n=40) followed by conventional angiography and MRI. DSA is
the modality with the highest standardization with “only” 27 methods in 108
publications, while MRI is the least standardized with 30 different methods in 46
publications.
It was not possible to determine excatly how many patients had collaterals assessed
with each modality, because in some instance multiple papers discussed cases
from the same study. However, publications assessing collaterals on DSA and
CT generally had much higher number of cases per study. The total number of
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patients who had collaterals assessed by DSA and CTA is 4-5 times higher than
the number of patients who had collaterals assessed by using MR-based imaging
modalities.
Almost all the studies assessed collaterals in acute stroke/TIA within 24 hours
from symptom onset (n=219) while 9 studies looked at mixed acute/non acute
cases, 5 studies did not state the time of measurement clearly, 1 had clinical setting
NA and 14 studies looked at stroke/TIA cases >24 h after symptom onset or
other pathologies. Eighty-one publications had reliability assessed for inter- and/or
intra-observer agreement. In two cases reliability was not assessed because the
scoring method was fully computational [67, 68] and in the remaining publications
(n=165) the reliability was not assessed/reported. Over half of the studies (n=142)
reported correlation of collaterals with clinical outcomes. Among the remaining
publications, 19 failed to prove correlation between collaterals and outcomes, 1
showed mixed positive/negative correlation between collaterals and good outcomes,
27 did not state whether there was a correlation and 59 did not have outcomes
available, since they were investigating other parameters or correlation between
different modalities.
Details of each recorded method are reported in tables 2.3, 2.6, 2.9 for DSA, CT and
MRI respectively and discussed below. Note that often two or more publications
reported data regarding a common study and consequently the same patients, thus
the numbers in the table are only indicative. It was not possible to determine
which and how many patients had been assessed multiple times. In the studies
that included both Moyamoya and non-Moyamoya patients ([69, 70]), only the
non-Moyamoya have been considered towards the count. Among the assessed
patients, 756 were control cases that were included for collateral analysis in three
separate publications by Maas et al., 2009 [71] (235 control patients, CTA-based
assessment), Qu et al, 2016 [72] (406 control cases, DSA-based assessment) and
Zou et al.[73] (115 control cases, DSA-based assessment).
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Table 2.2: Overview of the systematic review’s results, showing for each modality how
many methods were found, how many publications, how many patients were
assessed by using each modality (see table footnote), how many publications
dealt with studies performed in acute settings, how many assessed reliability
and how many found a correlation between collaterals and clinical outcomes.
Note that the line for “All” publications is not the sum of the above lines
because many papers discussed ≥2 imaging modalities/scoring methods.
Imaging
type
Methods Publ. N. of
patients
Acute
setting
Assessed
reliability
Corr. w/
outcome
DSA 27 108 13001∗ 88 21 60
CT 40 128 16851∗ 121 50 79
MRI 30 46 3272∗ 35 20 21
TCD 1 1 53 0 0 1
All 93 248 30857∗ 219 81 142
∗Estimate. In some instances multiple paper regarding the same studies have been identified and it is not pos-
sible to determine the correct number of overlapping cases.
2.3.2 Collaterals assessment with catheter angiography
DSA is still considered as the gold standard for measuring collaterals. A total of
108 publications had LM collaterals assessed by 27 different criteria using DSA. 88
assessed collaterals in acute stroke/TIA, 5 assessed a mix of acute/non acute stroke
patients with ICA and/or MCA stenosis/occlusion [70, 74, 75, 76, 77], 3 studies did
not report the time from symptom onset [78, 79, 72], 1 study assessed LM collaterals
in patients undergoing balloon test occlusion (BTO) of ICA for aneurysm/dissection
[80] and 11 assessed non-acute patients with minor symtomatic/asymptomatic TIA,
retinal ischemia, atherosclerotic or non atherosclerotic intracranial stenosis in the
ICA, MCA, vertebral artery (VA), basilar artery (BA) or vertebro-basilar artery
(VBA) [81, 82, 83, 84, 85, 86, 87, 88, 67, 69, 89, 73].
Six publications reviewed collateral flow for posterior circulation occlusion only
[90, 91, 82, 92, 93, 94], while the remaining assessed collaterals in anterior circulation
alone or in both anterior and posterior circulation.
One method (n. 4, ASITN/SIR scale) had both inter/intra-rater agreement as-
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sessed in one publication ([95], kinter=0.872, kintra=0.994) and only inter-observer
agreement assessed in the rest of the studies where it was adopted (10 papers,
[96, 47, 97, 39, 98, 79, 87, 99, 100, 73]). One method (8) had only intra-observer
agreement assessed (2 publications, k=0.81 [49, 101]), 4 methods (n. 1, 6, 21, 27)
had only inter-observer agreement assessed (5 publications, [102, 91, 103, 104, 105])
and the rest did not have reliability assessed. Where reported, the reliability was
assessed using Cohen’s kappa coefficient (k) and the resulting agreement was good
(0.60<k<0.80) or very good (0.80<k<1). If not specified in the subscript, the k
coefficient is always referred to inter-rater agreement (as opposed to intra-rater
agreement).
The most commonly reported scoring method on DSA is the American Society of
Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology
scale (ASITN/SIR), n. 4 in table 2.3, which appears in 56 publications. This scale
consists of 5 grades assigned based on the number and rapidity of collaterals vessels
[37]. The second most frequent scale, adopted in 8 publications, was proposed
by Christoforidis et al. [61] and is based on the extent of retrograde contrast
opacification of vessels within the occluded territory on delayed images. Arnold et
al. (method 3), proposed a simpler classification with only poor and good collaterals,
based on the extend of LM anastomoses in the occluded territory (more/less than
half) [63, 46, 64, 65, 106, 107, 108]. None of the publications assessed reliability.
One grading method (n. 22 table 2.3), first reported by Qureshi et al. and found in
5 publications, assigned scores based on the angiographic appearance of occlusion
and incorporating both anatomic sites and collateral pathways to the affected
region. None of the publications using this method and included in the systematic
review assessed the reliability, although a study published before 2009 showed good
inte-observer reliability (k=0.73), as reported in McVerry’s systematic review [29].
Ali et al. proposed to divide the ischaemic area in 3 equal parts and score each
with 0-1 depending on the capillary blush, then obtain a capillary index score (CIS)
by summing the individual values [109, 110, 111, 112, 103]. The reliability for this
method (n.1 in table 2.3) was tested only in one publication with 2 raters and
resulted in an inter-rater agreement of k=0.73 [103].
All remaining methods were reported only in 3 or fewer publications. Among
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these, 5 scoring systems classified collaterals only qualitatively, based on different
criteria: patency of specific vessels (n. 36), good/poor visualization of filling in
superior cerebellar artery (SCA) (n. 12), extent of cortical branches (n. 38),
primary/secondary collaterals (n. 7) or antegrade/retrograde flow (n. 20). One
paper reported a quantitative collateral measurement with no explicit grading
based on the time that contrast agent takes to reach its peak value in the target
downstream territory and the maximum contrast intensity within the duration of
DSA acquisition (n. 37). The remaining methods proposed various scales, with
number of grades varying from 3 to 6, based on either the absolute number of
individual leptomeningeal vessels visualized at angiography, the anatomic extent
and/or rapidity of vessel filling, or a combination of the two.
In 25 papers angiographically defined collaterals were compared with collaterals
assessed on one or more other modality. Eight papers compared DSA with CT-
methods [70, 113, 114, 91, 115, 58, 95, 87]. All papers reported good agreement
between the different modalities, apart from two cases. Shin et al., compared
DSA with both CTA-source images (CTA-SI) and dual-phase CTA and found that
DSA-collaterals agreed well with those assessed on dual-phase CTA but less with
those assessed on CTA [116]. Sung et al. found no significant correlation between
DSA-defined collaterals and CTA-defined collaterals and showed the CTA defined
collaterals were better associated with outcome [117]. Fifteen papers compared DSA
with MR methods, of which 6 were looking at hyperdense vessel sign (HV sign or
HVS) on fluid-attenuated inversion recovery (FLAIR)-MRI [118, 83, 74, 75, 79, 119]
and 9 at other MR-based parameters, such as dynamic contrast enhanced (DCE)
T1-MRI [70], dynamic susceptibility contrast enhanced MR perfusion (DSC-MRP)
[32, 120], DSC diffusion-weighted imaging (DWI) [121], MR perfusion-weighted
imaging (PWI) [99], contrast enhanced MR angiography (CE-MRA), time-of-flight
MR angriography (TOF-MRA) [122], 3D pseudo-continuous arterial spin labeling
(pCASL) [67], arterial transit artifact (ATA) from ASL-MR [69] (for patients with
non atherosclerotic intracranial stenosis only) and 3D multi-inversion time ASL
(mTI-ASL) [89]. One study [123] found that HV sign on FLAIR-MRI was associated
with angiographic collaterals but the meaning differed depending on perysilvian
sulcal effacement (PSE) status: if PSE was present, absence of HV was associated
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with poor collaterals, while in absence of PSE, absence of HV was associated with
good collaterals. In all these cases DSA compared well with the other modalities.
In a study by Pop et al. [105] collaterals were assessed as HV on FLAIR imaging
to select patients and then measured on DSA, but the two modalities were not
compared. Three studies [124, 125, 94] used a mix of different modalities to assess
collaterals based on what scans the patients had available, but did not compare
them.
Table 2.3: DSA-based scoring methods for LM collaterals.
Description Grades First author,
year (Cases)
Acute/
Non
acute
Reliability
assessed
Prognostic
value
1 Capillary blush in
ischaemic area
receiving retrograde
flow through pial
collaterals or very late
antegrade flow
0-3,
dichotomized
in poor (0,1)
vs favorable
(2,3)
Ali, 2013 [109] (26) Acute No Beneficial
Ali, 2014 [110] (28) Acute No Beneficial
Ali, 2015 [111] (78) Acute No Beneficial
Fahed, 2016 [112]
(62)
Acute No No effect
Labeyrie, 2016
[103] (146)
Acute Yes, k=0.73 Beneficial
2 Retrograde filling
of BA and superior
cerebellar artery and
presence of bilateral
anastomoses of cerebel-
lar arteries or PCAs
Qualitative
classification
in 4 types, no
scores
Alqadri, 2013 [90]
(24)
Acute No Beneficial
3 LM anastomoses in the
occluded territory
filling by less/more
than half
Poor vs Good Arnold, 2014 [63]
(389)
Acute No Beneficial
Galimanis, 2012
[46] (623)
Acute No Beneficial
Jung, 2012 [64]
(24)
Acute No Beneficial
Luedi, 2014 [65]
(1000)
Acute No Beneficial
Meyer, 2009 [106]
(1000)
Acute No Beneficial
Mono, 2012 [107]
(567)
Acute No Beneficial
Verma, 2014 [108]
(33)
Acute No Beneficial
4 Rapidity and extent of
retrograde collateral
flow (ASITN/SIR)
0-4 Bang 2011, [96, 47]
(222)
Acute Yes,
k=0.896
Beneficial
Brekenfeld, 2009
[126] (12)
Acute No NA
– continues on next page –
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Table 2.3 – continued from previous page
Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
Chen, 2015 [113]
(75)
Acute No Beneficial
Cohen, 2013 [127]
(31)
Acute No NS
He, 2013 [82] (21) Non acute No NA
Hwang, 2015 [97]
(207)
Acute Yes, k-0.864 Beneficial
Hwang, 2016 [128]
(163)
Acute No Beneficial
Imai, 2011 [129]
(90)
Acute No No effect
Jeong, 2014 [130]
(141)
Acute No Beneficial
Jeong, 2015 [131]
(134)
Acute No Beneficial
Jung, 2013 [39]
(44)
Acute Yes,
k=0.636
Beneficial
Khatri, 2014 [132]
(240)
Acute No Beneficial
Kim, 2009 [133]
(41)
Acute No NA
Kim, 2011 [134]
(149)
Acute No NA
Kim, 2011 [123]
(96)
Acute No NA
Kim, 2012 [95] (54) Acute Yes,
kinter=0.872,
kintra=0.994
NA
Kim, 2014 [32]
(134)
Acute Yes, k=0.80 Beneficial
Kurre, 2016 [135]
(73)
Acute No NS
Lau, 2012 [78] (69) NS No Beneficial
Lee, 2014 [98]
(104)
Acute Yes,
k=0.821
NA
Lee, 2015 [136]
(98)
Acute No NA
Lee, 2015 [120]
(66)
Acute No Beneficial
Liebeskind, 2011
[85] (287)
Non acute No NA
Liebeskind, 2011
[86] (287)
Non acute No Beneficial
– continues on next page –
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Table 2.3 – continued from previous page
Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
Liebeskind, 2014
[66] (276)
Acute No Beneficial
Liebeskind, 2014
[137] (119)
Acute No Beneficial
Liebeskind, 2016
[138] (119)
Acute No NA
Liu, 2014 [76] (103) Mixed No No effect
Liu, 2016 [79] (101) NS No NS
Liu, 2016 [87] (35) Non acute Yes,
k=0.090
NS
López-Cancio, 2014
[88] (136)
Non acute No NA
Lyu, 2015 [67] (21) Non acute No NA
Marks, 2014 [139]
(60)
Acute No Beneficial
Nicoli, 2014 [99]
(57)
Acute No Beneficial
Olivot, 2014 [140]
(56)
Acute No Beneficial
Park, 2014 [77]
(98)
Mixed No NS
Park, 2015 [141]
(37)
Acute No Beneficial
Park, 2016 [142]
(105)
Acute No NS
Pereira, 2013 [143]
(202)
Acute No Beneficial
Potreck, 2017 [121]
(47)
Acute No NS
Sanossian, 2009
[119] (74)
Acute No NA
Sanossian, 2011
[144] (102)
Acute No NA
Seet, 2012 [125]
(21)
Acute No Beneficial
Sheth, 2016 [145]
(117)
Acute No Beneficial
Shi, 2010 [146]
(159)
Acute No No
Shimoyama, 2013
[100] (93)
Acute Yes,
k=0.817
Beneficial
Shin, 2014 [116]
(43)
Acute No Beneficial
– continues on next page –
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Table 2.3 – continued from previous page
Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
Singer, 2015 [93]
(124)
Acute No Beneficial
Singer, 2015 [147]
(160)
Acute No Beneficial
Spiessberger, 2015
[148] (38)
Acute No NA
Sung, 2015 [117]
(30)
Acute No Beneficial
Verma, 2015 [149]
(74)
Acute No Beneficial
Wen, 2016 [150]
(18)
Acute No Beneficial
Wu, 2016 [89] (25) Non acute No NA
Zou, 2013 [73]
(211)
Non acute Yes, k=0.4-
1
NA
5 Extent of anterograde
and retrograde vessel
filling
Absent,
minimal,
moderate,
maximal
Jung, 2011, [92]
(106)
Acute No Beneficial
Liebeskind, 2011
[85] (287)
Non acute No NA
6 Extension and stasis of
retrograde reperfusion
in cortical ACA-MCA
territories
0-5 Consoli, 2016 [102]
(103)
Acute Yes, k=0.83 Beneficial
Mangiafico, 2013
[151] (57)
Acute No Beneficial
Mangiafico, 2014
[152] (103)
Acute No Beneficial
7 Qualitative classifica-
tion in primary (AcoA,
PCoA) and secondary
(ophthalmic, LM)
Primary vs
Secondary
Cheng, 2012 [81]
(38)
Acute No NA
8 Extent of retrograde
contrast opacification
within occluded
territory on delayed
angiographic images
1-5 Christoforidis, 2009
[49] (104)
Acute Yes,
kintra=0.81
Beneficial
Christoforidis, 2010
[153] (67)
Acute No Beneficial
Christoforidis, 2011
[101] (112)
Acute Yes,
kintra=0.81
Beneficial
Flores, 2015 [115]
(81)
Acute No Beneficial
Khatri, 2011 [154]
(16)
Acute No NA
Lazzaro, 2011 [155]
(104)
Acute No NA
Ribo, 2011 [156]
(61)
Acute No Beneficial
– continues on next page –
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Table 2.3 – continued from previous page
Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
Sargento, 2012
[157] (118)
Acute No Beneficial
9 Ratio between
parenchyma supplied
by collaterals and area
that should be supplied
by thrombosed vessel
Poor, fair,
good
Cohen, 2012 [158]
(17)
Acute No Beneficial
10 Leptomeningeal filling
of MCA vasculature
distal to the occlusion
0-3 Ernst, 2015[122]
(44)
Acute No NA
11 Extent of retrograde
contrast opacifica-
tion within occluded
territory on delayed
angiographic images
1-4 Finistis, 2014 [22]
(25)
Acute No No
12 Posterior circulation:
visualization of filling
of SCA; anterior circu-
lation: extent of filling
of occluded territory
Poor vs good Qu, 2016 [72] (800) NS No NA
13 Extent of collateral
supply in occluded
territory compared to
contralateral side
Poor,
moderate,
good
Arnold, 2015 [159]
(464)
Acute No Beneficial
Gratz, 2014 [160]
(226)
Acute No Beneficial
14 Contrast filling of
ACoA, PCoA, or oph-
thalmic arteries
0-3 Sato, 2014 [80] (31) NA NA NA
15 Extent of contrast
filling in occluded
territory
1-3 Drewer-Gutland,
2015 [161] (155)
Acute No No
Hesselmann, 2012
[58] (31)
Acute No Beneficial
16 Retrograde contrast
opacification of ves-
sels within occluded
territory on delayed
angiographic images
1-3 Huang, 2012 [118]
(29)
Acute No NS
17 Filling extent of at risk
territory in 15
ASPECTS areas
0-3 Chen, 2015 [70] (7) Mixed No NS
Roach, 2016 [69]
(11)
Non acute No NA
18 Extent of retrograde
flow in MCA
Poor vs Good Gasparotti, 2009
[162] (27)
Acute No NS
– continues on next page –
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Table 2.3 – continued from previous page
Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
19 Visual inspection of
anterior circulation and
LM collaterals
Poor,
moderate,
good
Lescher, 2015 [124]
(39)
Acute No Beneficial
20 Provenience of flow on
DSA
Antegrade,
retrograde
Liu, 2011 [74] (233) Mixed No NA
Liu, 2012 [75] (11) Mixed No NA
21 Retrograde
opacification in 5
cortical regions
0-5 Pop, 2014 [104]
(49)
Acute Yes, k=0.77 Beneficial
Pop, 2016 [105]
(89)
Acute Yes, k=0.77 Beneficial
22 Angiographic
appearance of
occlusion incorporating
anatomic site and
collateral pathway to
affected region
0-5 Hassan, 2010 [163]
(196)
Acute No NS
Liebeskind, 2011
[85] (287)
Non acute No NA
Qureshi, 2009 [164]
(101)
Acute No NA
Qureshi, 2015 [165]
(150)
Acute No NA
Shao, 2016 [166]
(6)
Acute No NS
23 Pial collaterals from
ACA
0-2 Rai, 2012 [167]
(89)
Acute No Beneficial
24 Filling extent of at risk
territory
None, partial,
full
Liebeskind, 2011
[85] (287)
Non acute No NA
25 Qualitative evaluation
based on patency of
PCoA and anasto-
moses between PICA
and SCA
N/A Van Houwelin-
gen2016 [94] (38)
Acute No No
26 Quantitative measure-
ment based on density
and time of contrast
agent to reach peak
value
N/A Wen, 2016 [150]
(105)
Acute Yes,
ICC=0.831
time,
ICC=0.983
density
Beneficial
27 Presence of cortical
branches from the
contralateral ACA or
from the PCA extend-
ing into the vascular
territory of the steno-
occlusive lesion
N/A Kawashima, 2011
[83] (68)
Non acute No NA
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Diagnostic/prognostic value of DSA-assessed collaterals
The prognostic value of DSA-assessed collaterals was discussed in 66 publications.
All but 7 publications showed that collaterals have a beneficial impact, meanining
that good collaterals are correlated with better outcome and/or poor collaterals
are correlated with worse outcomes. Six publications ([112, 22, 129, 76, 146, 94])
found no correlations between collaterals and outcomes. Hwang et al. showed
that excellent collaterals are associated with delayed re-occlusion[128]. Among the
studies that did not assess the prognostic value of collaterals, 30 studies did not
discuss outcomes (prognostic value NA), while 12 studies analyzed outcomes but
did not state whether there was an association with collaterals (prognostic value
NS).
A number of different outcome parameters have been associated with the grade
of collaterals (see table 2.4 for a detailed list). The follow-up parameter most
frequently adopted to assess the impact of collaterals was the modified-Rankin
Scale score at 3 months: good collaterals were correlated with 3-month mRS≤2
in 26 papers while 3 studies reported a correlation between poor collaterals and
mRS=3-6. In addition, Lau et al. observed a correlation with mRS at 3 months and
collateral score combined with antegrade score of blood flow through the clot ([78]).
Lescher et al. found a trend but no statistical significance between good collaterals
and mRS [124]. Two papers reported a correlation between good collaterals and
mRS≤2 at discharge. One paper did not specify the time at which mRS was
assessed ([89]).
The second most commonly investigated follow-up parameter was mortality/survival
(11 papers): 5 publications found correlations with good collaterals and survival
while 6 reported correlation between poor collaterals and mortality. Good collaterals
were also correlated with smaller final infarct volume (8 papers), smaller infarct
growth (7 papers) and ratio of penumbra loss (1 paper). 12 publications reported a
correlation with reperfusion or recanalization following treatment (either mechanical
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Table 2.4: List of outcome parameters most frequently reported to have a correlation
with DSA-assessed collaterals and corresponding publications.
Outcome parameter Publications
mRS ≤2 at 3 months 29 papers: [109, 110, 111, 103, 46, 159, 97, 128, 132, 32, 66, 137, 141,
143, 125, 100], [116, 93, 147, 150, 102, 151, 152, 156, 58, 167], [89]1, [78],
[124]2
mRS≤2 at discharge 2 papers: [131, 145]
Survival/mortality 11 papers: [46, 32, 92, 102, 159]/[63, 64, 65, 107, 66, 167]
Final infarct volume 8 papers: [110, 145, 147, 149, 156, 157, 105, 104]
Infarct growth 7 papers: [47, 58, 32, 104, 120, 139, 145]
Recanalization as TICI
2b-33
2 papers: [93, 156]
Recanalization as TIMI
2-33
5 papers: [65, 47, 66, 99, 167]
Reperfusion (TICI)3 5 papers: [66, 137, 139, 147, 160]
Intracranial hemor-
rhage/HT
8 papers: [46, 65, 106, 137, 49, 153, 114, 96]
Favorable neurological im-
provement (NIHSS drop):
4 papers: [130, 101, 157, 32]
24 h ASPECTS 2 papers: [137, 152]
NIHSS at 7 days/discharge 3 papers: [137, 102, 156]
Ratio of penumbra loss 1 paper: [39]
Length of hospitalization 1 paper: [145]
Recurrency of TIA/stroke 1 paper: [78]4
Infarct expansion in hyper-
glycemic patients
1 paper: [100]
1 Does not specify time of mRS evaluation.
2 Trend only.
3 Following treatment (either by thrombolysis or mechanical intervention).
4 Collateral score combined with antegrade flow score.
intervention or thrombolysis). The definition of follow-up recanalization was not
homogeneous: 2 papers used a TICI score of 2b-3 to define good recanalization
([93, 156], while 5 papers reported good recanalization as a TIMI score of 2-3
[65, 47, 66, 99, 167]. Poor collaterals were correlated with intracranial hemorrhage
and hemorrhagic transformation (HT) in 8 publications. Other less frequent
correlations are listed in table 2.4.
Better/poorer DSA-assessed collaterals were also correlated with a number of base-
line parameters, most importantly lower/higher NIHSS, higher/lower ASPECTS
score and baseline DWI lesion volume (table 2.5). 7 of the studies that investigated
collaterals found a correlation between good scores and presence of the HV sign.
In particular one study by Kim et al. found that in presence of perysilvian sulcal
effacement (PSE) the HV sign was predictive of good collaterals, but in absence of
PSE a missing HV sign was indicative of good collaterals. Three papers reported a
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correlation between the degree of collaterals and stroke subtype. Better collaterals
were associated with intracranial large artery atherosclerotic stroke, while worse
collaterals were associated with cardioembolic stroke [32, 134, 133]. Two papers
reported opposite correlations with the degree of stenosis: Liebeskind et al. found
that better collaterals were associated with higher degree of stenosis [85], while
Liu et al. observed worse collaterals in patients with higher degree of stenosis
[87]. 4 papers found a correlation between collaterals and the location of occlusion
although there is discrepancy among the associations detected: in a study by Marks
et al. better/worse collaterals were observed in patients with ICA/MCA occlusions
respectively [139], while Mangiafico and Consoli observed more MCA occlusion and
less ICA occlusion in their good collaterals group of patients [102, 152]. Labeyrie
et al. investigate patients with M1 and M2 occlusion and found that patients with
isolated occlusions are more likely to have better collaterals than patients with
tandem M1-ICA or M2-ICA occlusions. Other less frequently observed correlations
are listed in table 2.5.
2.3.3 Collaterals assessment with computed tomography
CT was the imaging modality with the highest number of publications (128), and
different assessment criteria (40). 21 methods used single phase CT angiography (1,
6, 7, 9, 11, 12, 13, 14, 16, 19, 20, 22, 23, 25, 26, 27, 28, 30, 32) and/or multi-phase
CTA (8, 17, 22, 40), 1 used time-invariant CTA (24), 1 used intravenously enhanced
flat-detector CT (IV-FDCT) (n=34), 7 used dynamic CTA (2 3, 10, 15, 21, 29,
31), 5 used CTP (33, 35, 36, 37, 39), 1 used three-phasic contrast-enhance (CE)
CT (38) and 3 used a combination of CTA and CT perfusion (4, 18) or CTA and
non-enhanced CT (NECT)/CECT (5).
121 studies assessed collaterals in acute stroke/TIA while 4 studies assessed a mix
of acute/non acute patients [70, 168, 169, 53] and 2 studies assessed LM collaterals
in non-acute patients: Sundaram et al. looked at cases of TIA/stroke due to
extracranial ICA occlusion within 3 weeks of symptom onset [170] and Liu et al.
looked at cases of symptomatic anterior circulation intracranial stenosis with or
without ischaemic stroke within 30 days after symptoms onset [87]. In one study
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Table 2.5: List of baseline parameters most frequently reported to have a correlation
with DSA-assessed collaterals and corresponding publications.
Baseline parameter Publications
NIHSS 16 papers: [103, 97, 131, 32, 120, 139, 145, 102, 151, 152, 160, 167, 114,
89, 46]
ASPECTS 7 papers: [103, 97, 137, 149, 156, 105, 114, 108]
HV sign 7 papers: [123, 79, 119, 118, 83, 74, 75]
DWI lesion volume 5 papers: [32, 120, 140, 145, 114, 105]
PWI lesion volume 1 paper: [139]
PWI/DWI ratio 1 paper: [145]
Location of occlusion 4 papers: [139, 102, 152, 103]
Subtype of stroke 3 papers: [133, 32, 134]
Age 3 papers: [103, 157, 167]
Prestroke statin use 2 papers: [98, 157]
CTP parameters 2papers: [102, 87]
Degree of stenosis 2 papers: [85, 87]
OTHER CORRELATIONS:
Degree of stenosis [85], sex (collaterals more recurrent in women) [86], Tmax value on DSC-MRP
maps [120], ALDH2 genotypes[72], rCVB on PWI [77], diabetes mellitus [87], history of hyperten-
sion [66], hyperlipidemia [100], history of congestive heart disease [66], elevated baseline blood glu-
cose [137], elevated systolic blood pressure [137, 156], cerebrovascular reactivity [69], shorter time
between symptom onset and arrival [138]
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the time from symptom onset was not stated clearly [84].
Two studies reviewed collateral flow for posterior circulation occlusion only [91, 94],
20 studies looked at both anterior and posterior circulation ([161, 84, 169] and
144-160) and the rest (106 publications) discussed collaterals in anterior circulation
alone.
Six methods (n. 14, 18, 24, 27, 37, 40) had both intra- and inter-observer agreement
assessed, while 15 (6-8, 13, 15-17, 19, 23, 25, 26, 29, 31, 35, 36) had only inter-rater
agreement and the rest had no agreement assessed. In total the publications that
discussed inter- and/or intra rater agreement for scoring method based on CT
imaging were 50 out of 128. Where reported, the reliability was assessed using
inter-/intra- class correlation coefficient (ICC) [171, 172, 52, 173, 174, 175, 60, 176],
Kendall’s W [168], Kα [177, 178, 179] or Cohen’s k (all other publications). One
study based on CTP that assessed collaterals based on the relative filling time
delay (rFTD) in the Sylvian fissure, calculated inter-rater agreement as the average
difference in rFTD assigned by the raters and found that it was good, ∆t<2 sec
[180]. Reliability assessment always resulted in good or very good inter-/intra-
observer agreement, apart from 4 publications where it was fair for at least one of
the collateral parameters assessed [181, 182, 177, 178].
A method proposed by Tan et al. [1] (n. 27 in table 2.6) was used in 54 of the
reviewed publications and is by far the most frequently adopted. This method looks
at the extent of filling in the occluded territory on CTA-MIP and assigns a score
of 0 for absent collaterals, 1 for collaterals filling ≤50% of the occluded territory, 2
for collaterals filling >50% but less than 100% of the occluded territory and 3 for
collateral filling equal to 100% of the occluded territory. This method had reliability
assessed in multiple studies and a good inter-rater agreement has been reported.
Among the remaining methods four have been used considerably more than the
others. One (n.18 in table 2.6), reported in 17 publications, is a method proposed
by Miteff et al. [27] for ICA/MCA complete occlusions and describes collaterals
as good, moderate or poor based on the degree of retrograde reconstitution of
the MCA up to the distal end of its occlusion. The second method (n. 13) is a
5-grade scale proposed by Maas et al. [71] and discussed in 16 papers that scores
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collaterals in the sylvian fissure and LM convexity based on the comparison with
the contralateral normal hemisphere. The third one (n.14, 14 publications) is a
20-point regional scoring system proposed by Menon et al. [52] that looks at the
extent of contrast opacification in arteries distal to the occlusion with respect to
contralateral hemisphere in the 6 ASPECTS cortical regions, Sylvian sulcus, ACA
territory and basal ganglia. The last one (n. 26, 9 publications), proposed by Souza
et al. [56], is a modification of the method used by Tan et al. with grading based
upon 50% of 1 MCA division rather then the whole occluded territory: 0=absent
collaterals in >50% of an MCA M2 branch territory, 1=diminished collaterals in
>50% of an MCA M2 branch territory, 2=diminished collaterals in <50% of an
MCA M2 branch territory, 3=collaterals equal to the contralateral hemisphere and
4=increased collaterals.
The rest of the CT-based methods appeared in 4 or fewer publications. Seven
methods had no explicit grading: method n. 3 in table 2.6 simply looked at
the presence/absence of delayed-late cortical vein filling as a sign of poor/good
collaterals, n. 10 evaluated contrast peak density vs contrast peak time with respect
to contralateral hemisphere on dynamic CTA with no explicit classification, n. 11
classified collaterals on CTA only anatomatically based on the origin of LM flow
from ACA or PCA, n. 36 and 39 looked at continuous values of contrast arrival time
on CTP, n. 38 looked at the ratio between the number of contrast enhancing MCA
branches in the occluded and normal side on three-phasic CECT, n. 28 looked at the
patency of posterior circulation vessels on CTA. The remaining had grading scales,
ranging from 3 to 10 grades. Assessing criteria included origin, velocity, number
and/or extent of contrast filling (either in the whole territory or only distal to the
occlusion), difference in intensity/distribution of specific arteries/veins between the
two hemispheres and Ktrans values from CTP scans in ischaemic area.
One publication compared CT-assessed collaterals with HV sign on FLAIR-MR
[183] and found a good correlation. Four studies (one discussed in three different
publications) compared conventional single-phase CTA with time-invariant CTA
[182], multi-phase CTA [171], dynamic CTA [184, 185, 186] and CTP [84], and
found that the lack of temporal resolution is a shortage in collaterals assessment
and that single-phase CTA is inferior to time-resolved modalities since sometimes
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collaterals appear poor just because the contrast has not reached the vessels yet
when single-CTA scans are acquired. Levi et al. [53] compared collaterals scored on
CTA with ACA flow diversion on TCD and found that flow diversion was strongly
associated with improved LM collaterals. Two studies [187, 188] used a mix of CTA
and MRA scans to assess collaterals based on what scans the patients had available,
but did not compare them. In addition, eight papers compared CT-scoring with
DSA-scoring, as discussed in the previous section (2.3.2).
Table 2.6: CTA-based scoring methods for LM collaterals.
Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
1 CTA Presence of sym-
metrical density of
signal intensity com-
pared with opposite
side
Inadequate vs
adequate
Ali, 2016 [187] (380) Acute No Beneficial
2 Dynamic
CTA
Origin, velocity and
extent of collateral
filling
Ant/Post/Ind +
velocity value +
less/greater 50%
extent
Beyer, 2015 [189]
(116)
Acute No Beneficial
Thierfelder, 2016
[190] (69)
Acute No No effect
3 Dynamic
CTA
Delayed-late
cortical vein filling
as sign of poor
collaterals
Presence or
absence of LCVF
Bhaskar, 2017 [191]
(117)
Acute No NA
Bhaskar, 2017 [192]
(119)
Acute No NA
4 CTA,
CTP
Retrograde vessel
filling distal to
occlusion
Poor, moder-
ate, good
Cheripelli, 2015 [34]
(118)
Acute No Beneficial
5 NECT,
CTA,
CECT
ASPECTS on CT
as predictor of
collaterals
0-10 Choi, 2011 [114] (55) Acute No Beneficial
6 CTA Arterial contrast
distal to the occlu-
sion and reconsti-
tution of veins in
affected hemisphere
Class 1-4 Parthasarathy, 2015
[193] (81)
Acute Yes,
k=0.828
Benefcial
– continues on next page –
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Table 2.6 – continued from previous page
Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
7 CTA Antegrade or ret-
rograde contrast
opacification of
vessels within oc-
cluded territory in
each of 6 segmen-
tal divisions of the
posterior circulation
arterial tree
6-1 Da Ros, 2016 [91]
(15)
Acute Yes Beneficial
8 CTA,
mp-
CTA
Filling of MCA pial
arterial circulation
on single or
multiphase CTA
Poor vs
moderate-good
Doucet, 2016 [194]
(31)
Acute No NA
Goyal, 2015 [50]
(315)
Acute No NA
Kim, 2016 [195] (71) Acute Yes,
k=0.728
mp-CTA,
k=0.747
CTA
NA
Muir, 2016 [196]
(65)
Acute No NS
9 CTA Extent of contrast
filling in occluded
territory
1-3 Drewer-Gutland,
2015 [161] (155)
Acute No No effect
Hesselmann, 2012
[58] (31)
Acute No Beneficial
10 dynamic
CTA
Regional evaluation
of contrast peak
density vs contrast
peak time with
respect to contralat-
eral hemisphere
NA Kawano, 2016 [197]
(66)
Acute No Beneficial
11 CTA Anatomical classi-
fication based on
presence/of anas-
tomoses between
distal segments
of ACA-MCA or
PCA-MCA
None, one
type or two
types present
Keedy, 2012 [84]
(135)
Acute No No effect
12 CTA Visual inspection of
anterior circulation
and LM collaterals
Poor, moder-
ate, good
Lescher, 2015 [124]
(39)
Acute No Beneficial
13 CTA-SI Comparison of
collaterals in
Sylvian fissure and
LM convexity with
Absent, less
than, equal to,
greater than,
exuberant
Agarwal, 2013 [198]
(39)
Acute Yes,
k=0.73
No effect
Arsava, 2014 [199]
(70)
Acute No NA
– continues on next page –
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Table 2.6 – continued from previous page
Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
contralateral hemis-
pere
Beyer, 2015 [200]
(136)
Acute No Beneficial
Higazi, 2016 [201]
(30)
Acute No NA
Kamalian, 2013
[202] (45)
Acute No NS
Lee, 2013 [203] (66) Acute No Beneficial
Lima, 2010 [55]
(196)
Acute No Beneficial
Lima, 2014 [204]
(126)
Acute No Beneficial
Maas, 2009 [71]
(369)
Acute No Beneficial
Malik, 2014 [205]
(82)
Acute No NS
Menon, 2015 [26]
(185)
Acute No Beneficial
Sundaram, 2017
[170] (65)
Acute Yes,
k=0.89
Beneficial
Volny, 2016 [206]
(86)
Acute No Beneficial
Yeo, 2015 [207]
(200)
Acute Yes,
k=0.82
Beneficial
Yeo, 2016 [208]
(100)
Acute Yes,
k=0.82
Beneficial
Yeo, 2016 [209]
(209)
Acute Yes,
k=0.82
Beneficial
14 CTA rLMC: Regional
assessment of
opacification from
LM vessel with
respect to
contralateral
hemisphere
0-20 Beyer, 2015 [200]
(136)
Acute No Beneficial
Frölich, 2014 [171]
(82)
Acute Yes,
ICC=0.81
spCTA,
ICC=0.78
tMIP
Beneficial
Gersing, 2017 [172]
(115)
Acute Yes,
ICCinter=0.87,
ICCintra=0.92
Beneficial
Malik, 2014 [205]
(82)
Acute No No effect
Menon, 2011 [52]
(138)
Acute Yes,
ICC=0.87
Beneficial
Menon, 2013 [210]
(206)
Acute No NS
– continues on next page –
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Table 2.6 – continued from previous page
Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
Nambiar, 2014 [211]
(84)
Acute No Beneficial
Qazi, 2015 [212]
(104)
Acute No NA
Tan, 2016 [213]
(283)
Acute Yes,
k=0.78
for AS-
PECT
and insu-
lar ribbon
regions,
k=0.23 for
others
Beneficial
Thierfelder, 2016
[190] (69)
Acute No No effect
von Baumgarten,
2016 [214] (103)
Acute No NS
Yeo, 2015 [207]
(200)
Acute Yes,
k=0.77
Beneficial
Yeo, 2016 [208]
(100)
Acute Yes,
k=0.77
Beneficial
Yeo, 2016 [209]
(209)
Acute Yes,
k=0.77
Beneficial
15 Dynamic
CTA
Anatomical extent,
prominence and
flow velocity of pial
arteries filling
retrogradely from
anterior/posterior
circulation
Extent:0-2,
Prominence:
null/minimal,
thin, same/more,
Time: 0-2
Beyer, 2015 [189]
(116)
Acute No Beneficial
Menon, 2013 [181]
(25)
Acute Yes,
k=0.73/0.88
extent,
k=0.60/0.88
promi-
nence,
k=0.40/0.72
velocity
NS
16 sp-CTA Extent and size of
pial arteries
backfilling frmo
ACA/PCA beyond
occlusion, as
compared to
contralateral
hemisphere
Minimal, poor,
fair, good,
excellent
Flores, 2015 [115]
(81)
Acute No Beneficial
Menon, 2015 [26]
(185)
Acute No Beneficial
Menon, 2015 [33]
(147)
Acute Yes
k=0.81
NA
Vagal, 2015 [215]
(53)
Acute No NA
17 mp-
CTA
Pial arterial filling
in the occluded
0-6 García-Tornel, 2016
[216] (108)
Acute Yes,
k=0.84
Beneficial
– continues on next page –
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Table 2.6 – continued from previous page
Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
territory compared
to similar arteries in
Menon, 2015 [33]
(147)
Acute Yes,
k=0.81
NA
contralateral hemi-
sphere
Seker, 2016 [217]
(51)
Acute No NA
18 CTA,
MIP,
CTP
Retrograde filling of
MCA
Poor, moderate,
good
Bhaskar, 2017 [191]
(117)
Acute No NA
Bhaskar, 2017 [192]
(119)
Acute No NA
Bivard, 2017 [19]
(1519)
Acute No Beneficial
Kawano, 2016 [197]
(66)
Acute Yes,
k=0.861
Beneficial
Levi, 2012 [53] (53) Mixed No Beneficial
Mair, 2015 [177]
(15)
Acute Yes,
αinter=0.56,
αintra=0.72
NA
Mair, 2017 [178]
(135)
Acute Yes,
α=0.56
Beneficial
Malik, 2014 [205]
(82)
Acute No NS
Miteff, 2009 [27]
(92)
Acute k=0.93 Beneficial
Nordmeyer, 2017
[218] (87)
Acute k=0.78 Beneficial
Parthasarathy, 2013
[219] (39)
Acute No Beneficial
Seet, 2012 [125] (21) Acute No Beneficial
Seker, 2016 [217]
(30)
Acute No NA
Yeo, 2015 [207]
(200)
Acute Yes,
k=0.91
Beneficial
Yeo, 2016 [208]
(100)
Acute Yes,
k=0.91
Beneficial
Yeo, 2016 [209]
(209)
Acute Yes,
k=0.91
Beneficial
Zareie, 2013 [220]
(53)
Acute No NS
19 CTA Difference in recon-
stitution of 4 given
veins between the
two hemispheres
0-2 Parthasarathy, 2013
[219] (39)
Acute Yes,
k=0.86
Beneficial
– continues on next page –
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Table 2.6 – continued from previous page
Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
20 CTA-
MIP
Vessels distribution
in Sylvian fissure
and LM convexity
0-3 Seeta, 2014 [221]
(87)
Acute No Beneficial
21 Dynamic
CTA
ASITN/SIR collat-
eral score applied to
CTA
0-4 Seker, 2016 [217]
(30)
Acute No NA
22 sp-CTA,
dy-
namic
CTA-
MIP
Extent of retro-
grade contrast
opacification of
vessels in occluded
territory on delayed
angiographic images
1-5 Seker, 2016 [217]
(30)
Acute No NA
23 CTA Extent of vascu-
larity at Sylvian
fissure and at cere-
bral convexity.
0-8 Seyman, 2016 [179]
(51)
Acute Yes,
α=0.96
Beneficial
24 TI-CTA Extent of filling in
territory of
occluded vessel
smaller/greater
than 50% as
compared to
contralateral side
1-4 Kaschka, 2017 [222]
(49)
Acute No NS
Rohan, 2014 [223]
(80)
Acute Yes NA
Smit, 2013 [182] (40) Acute Yes,
kinter=0.68,
kintra=0.78
Beneficial
25 CTA-
MIP
Extent of filling in
MCA-M2 segment
0-3 Song, 2015 [48] (91) Acute Yes,
k=0.697
Beneficial
26 CTA Extent of filling in
MCA-M2 segment
0-4 Elijovich, 2015 [224]
(50)
Acute No Beneficial
Giurgiutiu, 2015 [24]
(73)
Acute No Beneficial
Karadeli, 2016 [183]
(39)
Acute No NA
Rusanen, 2015 [173]
(104)
Acute Yes,
k=0.68,
ICC=0.87
Beneficial
Rusanen, 2015 [174]
(105)
Acute Yes,
k=0.68,
ICC=0.87
Beneficial
Saarinen, 2014 [175]
(105)
Acute Yes,
k=0.68,
ICC=0.87
Beneficial
Sillanpää, 2015 [225]
(105)
Acute Yes,
k=0.68,
ICC=0.87
Beneficial
– continues on next page –
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Table 2.6 – continued from previous page
Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
Souza, 2012 [56]
(197)
Acute Yes,
k=0.76
Beneficial
Timpone, 2015 [226]
(55)
Acute Yes,
k=0.44
Beneficial
27 CTA Extent of filling in
territory of
occluded vessel
smaller/greater
than 50% as
compared to
contralateral side
0-3, often
dichotomized
into poor(0-1) vs
good (2-3)
Agarwal, 2013 [198]
(39)
Acute Yes,
k=0.73
No effect
Agarwal, 2015 [227]
(53)
Acute No NS
Angermaier, 2011
[228] (25)
Acute Yes,
k=0.71
Beneficial
Angermaier, 2016
[229] (63)
Acute No No
Aoki, 2014 [230] (56) Acute No Beneficial
Berkhemer, 2016
[231] (493)
Acute Yes,
k=0.60
Beneficial
Beyer, 2015 [189]
(116)
Acute No Beneficial
Beyer, 2015 [200]
(136)
Acute No Beneficial
Brunner,2014 [232]
(246)
Acute Yes, k=1.0 Beneficial
Chen, 2015 [113]
(75)
Acute No Beneficial
Cheng, 2015 [233]
(76)
Acute No Beneficial
Dehkharghani, 2015
[7] (47)
Acute Yes,
Pearson-
k=0.85
No effect
Dehkharghani, 2016
[234] (54)
Acute No No effect
Dippel, 2016 [235]
(233)
Acute No NS
Eilaghi, 2013 [236]
(114)
Acute No Beneficial
Espinosa, 2015 [237]
(150)
Acute No Beneficial
Fanou, 2015 [238]
(395)
Acute No Beneficial
García-Tornel, 2016
[216] (108)
Acute Yes,
k=0.84
Beneficial
Gerber, 2016 [168]
(93)
Mixed Yes,
Kendall’s
W=0.752
Beneficial
– continues on next page –
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Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
Grech, 2014 [239]
(55)
Acute NS Beneficial
Higazi, 2016 [201]
(30)
Acute No No effect
Hom, 2011 [240]
(32)
Acute No NA
Huisa, 2014 [241]
(165)
Acute No NS
Kaschka, 2016 [222]
(49)
Acute No NS
Kawiorski, 2016
[242] (34)
Acute No NA
Kheradmand, 2014
[169] (18)
Mixed No Beneficial
Kim, 2010 [243] (68) Acute Yes,
k=intra0.79
Beneficial
Kim, 2015 [244] (71) Acute No Beneficial
Lin, 2012 [245] (84) Acute No Beneficial
Malik, 2014 [205]
(82)
Acute No No effect
Man, 2015 [246] (97) Acute No Beneficial
Menon, 2015 [26]
(185)
Acute No Beneficial
Mortimer, 2013 [247]
(15)
Acute No NA
Nordmeyer, 2017
[218] (87)
Acute Yes,
k=0.93
Beneficial
Ozkul, 2014 [248]
(86)
Acute No Beneficial
Pfaff, 2016 [188] (33) Acute No NS
Power, 2015 [45]
(48)
Acute No NA
Renú, 2017 [249]
(146)
Acute No NS
Shin, 2014 [116] (43) Acute Yes,
k=0.475
Beneficial
Smit, 2013 [182] (40) Acute Yes,
kinter=0.57,
kintra=0.73
Beneficial
Soares, 2010 [250]
(22)
Acute No Beneficial
Sung, 2015 [117]
(30)
Acute No Beneficial
– continues on next page –
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Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
Tan, 2009 [60] (85) Acute Yes,
ICC=0.87
Beneficial
Urra, 2014 [251] (78) Acute No No effect
van Seeters, 2015
[252] (1374)
Acute No Beneficial
van Seeters, 2016
[253] (906)
Acute No Beneficial
van Seeters, 2016
[254] (484)
Acute No Beneficial
Van Den Wijngaard,
2015 [184] (70)
Acute No Beneficial
Van Den Wijngaard,
2016 [185] (61)
Acute No Beneficial
Van Den Wijngaard,
2016 [186] (88)
Acute No Beneficial
Yeo, 2015 [207]
(200)
Acute Yes,
k=0.93
No effect
Zhu, 2013 [255]
(165)
Acute No NS
Zhu, 2013 [256]
(165)
Acute No No effect
Zhu, 2015 [257]
(103)
Acute No No effect
28 CTA Patency of vertebral
arteries, PCoA
and anastomosis
between PICA and
SCA
N/A Van Houwelingen,
2016 [94] (38)
Acute No No effect
29 Dynamic
CTA
Extent and filling
velocity of vessels
below and above
caudate nuclesu
Good and
fast, good and
slow, poor
and fast, poor
and slow
Wijngaard, 2015
[184] (70)
Acute Yes,
k=0.86
Beneficial
Wijngaard, 2016
[185] (61)
Acute Yes,
k=0.88
Beneficial
Wijngaard, 2016
[186] (88)
Acute No Beneficial
30 CTA Comparison of
Sylvian collaterals
with contralateral
hemispere
0-2 Yoo, 2011 [258] (48) Acute No NA
– continues on next page –
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Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
31 4D
CTA
rLMC on peak
phase (rLMC-P)
and tMIP (rLMC-
M)
poor, interme-
diate, good
Zhang, 2016[176]
(80)
Acute Yes,
ICC=0.85
rLMC-P,
ICC=0.87
rLMC-M
Beneficial
32 CTA Filling extent of at
risk territory in 15
ASPECTS areas
0-3 Chen, 2015 [70] (7) Mixed No NS
33 CTP Arrival time of
retrograde flow
downstream from
arterial region of
interest
Poor, good Ahn, 2015 [259] (39) Acute No Beneficial
34 IV
FDCT
Extent of retro-
grade contrast
opacification of ves-
sels within occluded
territory
1-5 Blanc, 2012 [260]
(14)
Acute No NS
35 CTP-SI,
MTT
maps
Extent of cortical
arteries in
hypoperfused MCA
territory as defined
by MTT maps
0-3 Calleja, 2013 [38]
(54)
Acute Yes,
k=0.724
Beneficial
Cortijo, 2014 [261]
(68)
Acute Yes,
k=0.724
NS
Liu, 2016 [87] (35) Non
acute
Yes,
k=0.794
NA
36 CTP-SI Relative filling time
delay (rFTD) in the
Sylvian fissure
N/A Cao, 2014 [180] (60) Acute Yes, ∆t<2 Beneficial
Kaschka, 2016 [262]
(121)
Acute No No effect
37 CTP Mean Ktrans val-
ues in ischaemic
cerebral area
1-4 Chen, 2015 [113]
(75)
Acute Yes,
kinter=0.905,
kintra=0.934
Beneficial
38 Three-
phasic
CECT
Ratio between
number of con-
trast enhancing
MCA branches
on occlusion and
contralateral side
N/A Jung, 2011 [263]
(11)
Acute No NA
39 CTP Functional assess-
ment based on
delayed arrival
of intravenous
contrast to brain
parenchyma
N/A Keedy, 2012 [84]
(135)
Non
acute
No Beneficial
– continues on next page –
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Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
40 MPCT Number and
rapidity of collateral
vessels filling
ASITN/SIR
scale (0-3)
Kim, 2012 [95] (54) Acute Yes,
kinter=0.813,
kintra=0.852
NA
Shin, 2014 [116] (43) Acute Yes,
k=0.776
Beneficial
Diagnostic/prognostic value of CT-assessed collaterals
The prognostic value of CT-assessed collaterals was discussed in 89 publications.
10 of these ([198, 229, 234, 161, 205, 190, 251, 94, 256, 262]) failed to demonstrate
a correlation between collaterals and outcomes, while the remaining proved that
collaterals are associated with a number of different parameters, such as mRS at
3 months/discharge, infarction volume, recanalization, recurrency of TIA/stroke,
mortality, intracranial haemorrhage, NIHSS and ASPECTS. Among the studies
that did not assess the prognostic value of collaterals, 21 studies did not discuss
outcomes (NA), while 18 studies analyzed outcomes but did not state whether
there was an association with collaterals (NS).
Table 2.7 lists the outcome parameters that have been associated with the grade of
collaterals.
The follow-up parameter most frequently adopted to assess the impact of collaterals
was again the modified-Rankin Scale score at 3 months: good collaterals were
correlated with 3-month mRSleq2 in 42 papers while 3 studies reported a correlation
betwwen poor collaterals and mRS=3-6 ([252, 254, 226]). Fanou et al. observed a
correlation between good collaterals and mRS≤2 at 3 months only in patients with
no recanalization [238] while Souza et al. reported the correlation only for untreated
patients [56]. Three papers reported a correlation between good collaterals and
mRS≤2 at discharge or at 6 months.
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Table 2.7: List of outcome parameters most frequently reported to have a correlation
with CT-assessed collaterals and corresponding publications.
Outcome parameter Publications
mRS ≤ 2 at 3 months 47 papers: [231, 113, 236, 237, 238]1, [216, 168, 239, 58, 26, 218, 116,
182, 117, 60, 184, 186, 207, 114, 91, 193, 38, 180, 222], [173, 174, 175, 48,
56]2, [176, 19, 171, 172, 203, 27, 52, 211, 219, 125, 221, 170, 213, 226,
252, 254, 208, 209]3
mRS≤ 2 at discharge 3 papers: [232, 179, 224]
≤ 2 at 6 months 3 papers: [55, 204, 178]
Death or discharge to facil-
ity other than home
1 paper: [187]
Final infarct volume 14 papers: [228, 189, 200, 238, 169, 116, 60, 253, 185, 197, 224, 113, 115,
56]
Infarct volume at 24 h 2 papers: [216, 193]
Infarct growth 6 papers: [58, 246, 218, 176, 27, 211]
Survival/mortality 8 papers: [232, 180]/[243, 218, 55, 204, 208, 209]3
ICH / HT 7 papers: [232, 218, 208, 209, 245, 248, 176]
Malignant brain edem 2 papers: [244, 206]
Reperfusion (TICI)4 2 papers: [113, 250]5
Recanalization (TIMI 2-3)4 1 paper: [228]
Early recanalization4 1 paper: [259]
Early neurological improve-
ment (ENI)
1 paper: [38]
Recurrency of TIA/stroke 1 paper: [84]
NIHSS at 7 days/discharge 2 papers: [216, 117]
24 h NIHSS 3 papers: [218, 174, 175]
24 h ASPECTS 3 papers: [180, 173, 175]
follow-up ASPECTS 1 paper: [52]
1 Correlation observed only for patients with no recanalization.
2 Correlation observed only for untreated patients.
3 Correlation observed only in univariable analysis.
4 Following treatment (either by thrombolysis or mechanical intervention).
5 Correlation with reperfusion in patients with no recanalization.
The second most commonly investigated follow-up parameter was final infarct
volume (14 papers): 11 publications found that better collaterals were correlated
with smaller final infarct volume and 3 reported that poor collaterals were cor-
related with larger infarct volume. Good/poor collaterals were also correlated
with survival/mortality (2/6 papers respectively) and correlations between poor
collaterals and intra-cranial haemorrhage and haemorrhagic transformation was
observed in 4 and 3 papers respectively. Other less frequent correlations are listed
in the table 2.7.
Better/poorer collaterals assessed with CT imaging were also correlated with a
number of baseline imaging and clinical parameters (table 2.8).
The baseline parameters most frequenlty observed to have a correlation with
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collaterals were NIHSS scores (17 papers) and ASPECTS scores (14 papers). Of
the 14 publications that reported a correlation with ASPECTS scores, all but two
used ASPECTS score measured on CTA. Rusanen et al. derived two ASPECTS
score from cerebral blood volume (CBV) and mean transit time (MTT) perfusion
maps, while Lee et al. used CBV-ASPECTS alone [174, 203]. Other baseline
perfusion parameters were found to have a correlation with the quality of collaterals
in six different publications.
After NIHSS and ASPECTS scores the baseline parameters which were most
frequently correlated with collaterals were infarct volume and penumbra, age and
perfusion/lesion mismatch. Interestingly, one group reported in 3 publications that
poor and good collaterals are associated with shorter and longer onset to treatment
time respectively, supporting the hypothesis that at least in some patients the
longer the lack of perfusion the more the amount of collaterals to compensate for
it [173, 174, 175].
Other less frequently observed correlations with baseline parameters are listed in
table 2.8.
2.3.4 Collaterals assessment with magnetic resonance imag-
ing
Collaterals were assessed with MRI in 46 publications using 30 different methods.
11 methods used MRA (1, 5, 6, 7, 9, 11, 12, 15, 26, 27, 30), 9 FLAIR-MRI (8, 11,
12, 13, 16, 17, 20, 23, 28), 7 PWI-MR (2, 9, 14, 21, 22, 24, 25), 4 ASL-MRI (4, 18,
19, 29) and 2 CE T1-MRI (3, 10).
35 studies assessed collaterals in acute stroke/TIA, while 4 looked at a mix of
acute/non acute patients [264, 70, 74, 75], 6 looked at non-acute patients [265, 83,
67, 69, 266, 89] and 1 had unclear acute/non acute setting [267].
Two studies assessed collateral flow for posterior circulation occlusion alone [268,
269], 7 looked at both anterior and posterior circulation [187, 270, 183, 68, 69, 119,
271] while the rest (37 publications) discussed collaterals in anterior circulation
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Table 2.8: List of baseline parameters most frequently reported to have a correlation
with CT-assessed collaterals and corresponding publications.
Baseline parameter Publications
NIHSS score 17 papers: [232, 236, 238, 216, 201, 180, 179, 24, 174, 175, 56, 176, 199,
172, 27, 52, 170]
ASPECTS 14 papers: [232, 205, 116, 38, 263, 179, 174, 225, 48, 172, 203, 55, 210,
52]
Age 7 papers: [198, 216, 205, 116, 173, 199, 210]
Sex 2 papers: [232, 179]
Leukoaraiosis volume 2 papers: [24, 199]
Infarct volume 10 papers: [228, 233, 201, 197, 261, 217, 179, 27, 215, 113]
Penumbra/lesion mismatch 5 papers: [198, 217, 27, 215, 214]
Perfusion lesion volume 1 papers: [197]
DWI lesion volume 3 papers: [193, 56, 230]
Baeline and 24 perilesional
hyperperfusion
2 papers: [192, 176]
Type of stroke 2 papers: [116, 125]
Location of occlusion 2 papers: [116, 173]
Presence of distal HV sign 1 paper[183]
Flow diversion 1 paper: [220]
Perfusion parameters 6 papers: [189, 7, 169, 60, 87, 261]
Late cortical vein filling 1 paper: [191]
Degree of stenosis 1 paper: [87]
Thrombus extent / clot
burden score
3 papers: [60, 212, 52]
History of hypertension 4 papers: [199, 172, 55, 210]
Shorter onset to treatment
time
3 papers: ([173, 174, 175])
OTHER CORRELATIONS (WITH POOR COLLATERALS):
Diabetes mellitus ([216, 38]), statin use [205], incomplete posterior circle of Willis ([254]), elevated
baseline blood glucose ([254, 24]), evelated systolic blood pressure ([173, 55]), metabolic syndrome
([210], raised serum uric acid ([210]).
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alone.
Three methods (14, 21, 30) had both intra- and inter-observer agreement assessed,
while 11 (2, 4, 6, 8, 9, 11, 12, 17, 18, 22, 23,) had only inter-rater agreement assessed,
2 (13, 29) only intra-rater agreement and the rest had no reliability assessed. In
total the publications that discussed inter- and/or intra-rater agreement for scoring
methods based on MRI were 19 out of 46. Two methods (7, 24) did not have
reliability assessment available because they were completely automated. Where
reported, the reliability was assessed using inter-/intra-class correlation coefficient
(ICC) [270, 268, 183, 272, 99, 264], Cohen’s Kappa (k) [69, 122, 79, 32], 252-259 or
Pearson’s kappa coefficient (kPearson) [89]. Reliability assessment always resulted in
good or very good inter-/intra-rater agreement, apart from 3 publications where it
was fair [273, 274, 69].
The most commonly used approach to measure collaterals on MRI consists in
detecting the presence of one or more distal hyperintense vessel sign(s) on FLAIR-
MRI (n. 8 in table 2.9). HV signs are described as focal, tubular or serpentine
hyperintensities in the subarachnoid space against the relative hypointensity of
cerebrospinal fluid (CSF). As opposed to other vessel signs that are associated with
arterial insufficiency, HV does not represent a thrombus but rather sluggish and
disordered blood flow which is supposedly due to leptomeningeal collaterals. This
hypothesis seems to be supported by the following consideration. It is generally
accepted that in presence of MCA occlusions the recruitment of leptomeningeal
collaterals is induced by a pressure gradient between the ACA or PCA territory
and a territory distal to the MCA occlusion site and that leptomeningeal collaterals
may decrease or disappear once the occluded MCA reopens and the pressure
gradient normalizes. Several studies in patients with ICA or MCA occlusion
reported that HV collateral signs on initial FLAIR MR imaging disappeared within
several days after early spontaneous recanalization or successful revascularization
via endovascular therapy, therefore strengthening the hypothesis that HV sign may
be used as an imaging marker for collaterals [28].
This association was first described by Lee et al. [275] and was used to assess
collateral flow in 10 of the publications analyzed by the review. Other scoring
48
2.3 Results
methods used the same criteria but introduced different grading scales (11, 12,
13, 16, 17, 20, 23). The second most common approach consists in applying the
ASITN/SIR scale to 4D angiograms or collateral flow maps obtained from MRP
(n. 9, 14). The rest of MRI-based methods appeared in only 2 or 1 publications
and used a number of different criteria, as described in table 2.9.
A number of publications compared MRI-assessed collaterals with other imaging
modalities as described in the previous sections (2.3.2, 2.3.3). In addition to these,
some papers reported a comparison or a combination of different methods both
based on MRI. Chen et al. [70] compared collaterals assessed on ASL-MRI and
collaterals assessed based on Ktrans maps from DCE T1 MRI with gold standard
DSA-collaterals and found good agreement for the second but poor for the first
method. Ernst et al. [122] compared collaterals assessed on CE-MRA and TOF-
MRA both visually and computationally with DSA-assessed collaterals and they
found that visual scores of CE but not TOF-MRA were as reliable a predictor
of outcome as DSA-collaterals, while in the computational approach both TOF-
and CE-MRA were predictive of penumbral reperfusion. Forster et al. [268] and
Gawlitza et al. [276] compared HV sign on FLAIR-MRI with collaterals measured
on 4D angiograoms from PWI raw images and found that there was no correlations
between the two methods, but that a combination of both parameters allows a
better characterization of collateral flow.
Table 2.9: MRI-based scoring methods for LM collaterals.
Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
1 MRA Presence of sym-
metrical density of
signal intensity com-
pared with opposite
side
Inadequate vs
adequate
Ali, 2016 [187] (380) Acute No Beneficial
2 4D an-
giograms
from
MRP
Flow appearing
within arterial
phase of perfusion
ASITN/SIR
scale (0-4)
Campbell, 2013
[270] (74)
Acute Yes,
ICC=0.85
Beneficial
Forster, 2014 [268]
(38)
Acute Yes,
ICC=0.85
Beneficial
Forster, 2015 [269]
(28)
Acute No Beneficial
– continues on next page –
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Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
Gawlitza, 2017 [276]
(39)
Acute No NA
3 DCE
T1-MRI
Volume transfer
constant (Ktrans)
values in ASPECTS
regions
0-3 Chen, 2015 [70] (7) Acute No NS
4 ASL-
MRI
Perfusion
with/without
arterial transit
artifact in
ASPECTS regions
0-3 Chen, 2015 [70] (7) Acute No NS
Roach, 2016 [69]
(11)
Non
acute
Yes, 3
readers,
k1,2=0.31-
0.36,
k2,3=0.48-
0.56
NA
5 7T
MRA
Vascular density
of collateral mi-
crovessels around
steno-occlusive
MCA
N/A Choi, 2013 [265] (9) No No NA
6 CE-
MRA,
TOP-
MRA
Visual inspection of
abundance of MCA
vascularity distal
to occlusion with
respect to normal
hemisphere
None/poor,
fair,
good/nor-
mal
Ernst, 2015 [122]
(44)
Acute Yes,
k=0.70
CE-MRA,
k=0.71
TOF-
MRA
Beneficial
7 CE-
MRA,
TOP-
MRA
Automated Col-
lateral Index (CI).
Ratio between hemi-
spheres of signal
intensity of MCA
vascular voxels dis-
tal to M1 calculated
by using atlas from
normal MRAs
range 0-1 Ernst, 2015 [122]
(44)
Acute NA Beneficial
8 FLAIR-
MRI
Presence of distal
hyperintense vessel
sign
N/A Forster, 2014 [268]
(38)
Acute No No effect
Gawlitza, 2014 [277]
(33)
Acute No No effect
Gawlitza, 2017 [276]
(39)
Acute No NA
Haussen, 2013 [273]
(49)
Acute Yes,
k=0.58
NA
Huang, 2012 [118]
(29)
Acute No Beneficial
– continues on next page –
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Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
Kim, 2011 [123]
(139)
Acute No NA
Lee, 2009 [275] (52) Acute No NA
Mourand, 2016 [278]
(41)
Acute No NS
Pop, 2016 [105] (89) Acute No NA
Sanossian, 2009
[119] (74)
Acute No NA
Kawashima, 2011
[83] (68)
Non
acute
No NA
9 Dynamic
MRA,
sub-
tracted
dy-
namic
MRP-SI
Number and
rapidity of collateral
vessels filling
ASITN/SIR
scale (0-4)
Hernández-Pérez,
2015 [279] (25)
Acute Yes,
k=0.93
NA
Villringer, 2016 [274]
(132)
Acute Yes,
k=0.58
Beneficial
10 CE
T1-MRI
Comparison of pial
and arachnoid en-
hancement between
hemispheres
Mild, equiv-
alent, promi-
nent
Hong, 2015 [267]
(31)
NA No NS
11 FLAIR-
MRI,
3D
TOF-
MRA
Prominence of PCA
laterality on
TOF-MRA and HV
sign on FLAIR as
marker of
collaterals
NA Chang, 2016 [264]
(87)
Mixed Yes,
ICC=0.924
PCA
laterality,
ICC=0.964
HV sign
NA
Ichijo, 2013 [280]
(50)
Acute No NA
12 FLAIR-
MRI,
3D
TOF-
MRA
Prominence of
PCA laterality
on TOF-MRA
and HV sign on
FLAIR as marker of
collaterals
PCA lateral-
ity:present/absent,
positive/nega-
tive. HV sign:
0-12
Ichijo, 2015 [28] (48) Acute Yes,
k=0.917
PCA lat-
erality,
k=0.772
HV
Beneficial
13 FLAIR-
MRI
Score based on
number, location
and prominence of
HV signs
0-2 Karadeli, 2016 [183]
(39)
Acute Yes, intra-
rater
ICC=0.74
NA
14 DSC-
MRP
Manually and
automatically
generated CF maps
from perfusion
ASITN/SIR
scale (0-4)
Kim, 2014 [32] (134) Acute Yes,
kinter=0.82,
kintra=0.88
Beneficial
Lee, 2015 [120] (66) Acute No Beneficial
– continues on next page –
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Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
Son, 2017 [281] (73) Acute Yes,
kinter=0.82,
kintra=0.84
Beneficial
15 MRA Visual inspection of
anterior circulation
and LM collaterals
Poor, moder-
ate, good
Lescher, 2014 [124]
(39 )
Acute No Beneficial
16 FLAIR-
MRI
Position of HV sign N/A Liu, 2011 [74] (233) Mixed No NA
Liu, 2012 [75] (11) Mixed No NA
17 FLAIR-
MRI
FHV extent and
prominence in
ASPECTS areas
with (FHV-I) or
without (FHV-O)
infarction
N/A Liu, 2016 [79] (101) NS Yes,
k=0.72,
FHV-
Total,
k=0.74
FHV-I,
k=0.71
FHV-O
Beneficial
18 multi-
delay
3D
cASL
Presence of arterial
transit artifact
(ATA) on CBV
maps in 10 different
cortical regions
0-2 Lou, 2017 [282] (53) Acute Yes,
k=0.83-
0.92
Beneficial
19 3D-
pCASL
Late arriving retro-
grade flow on CBF
maps
N/A Lyu, 2015 [67] (21) Non
acute
NA NA
20 FLAIR-
MRI
Location of HV sign
closest to occlusion
1-5 Maurer, 2016 [283]
(158)
Acute No No effect
21 MR-
PWI
Ratio between crit-
ically and moder-
ately hypoperfused
area
Critical, mod-
erate, total
hypoperfused
volume
Nicoli, 2013 [272]
(64)
Acute Yes,
interrater-
ICC=0.92/0.90/0.94,
intrarater-
ICC=0.85
Beneficial
22 MR-
PWI +
DWI
Volume of tissue
with arterial delay
time>6
N/A Nicoli, 2014 [99] Acute Yes,
ICC=0.994
Beneficial
23 7FLAIR-
MRI
Presence of HV sign
on 10 different
horizontal slices
starting from first
M1-MCA
appearance
Low, medium,
high
Chang, 2016 [264] Mixed Yes,
ICC=0.964
NA
Olindo, 2012 [284]
(105)
Acute Yes,
k=0.80
No effect
24 PWI-
MR
Volume of tissue
with Tmax delay >
12 s as marker or
poor collaterals
Poor vs non-
poor
Parsons, 2010 [68]
(98)
Acute NA Beneficial
– continues on next page –
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Modality Description Grades First author Acute/
Non
acute
Reliability
assessed
Prognostic
value
25 DSC-
PWI
Hypoperfusion
intensity ration
given by ratio of the
Tmax>10s lesion
over Tmax>6 s
lesion volume
Poor, moder-
ate, good
Potreck, 2017 [121]
(47)
Acute NA Beneficial
26 quantitat.
MRA
(QMRA)
Asymetrically
increased flow ipsi-
lateral to a parent
artery affected by
steno-occlusive
disease
N/A Ruland, 2009 [266]
(16)
Non
acute
No NA
27 MRA rLMC: Regional
assessment of LM
vessel with respect
to contralateral
hemisphere in M1-
M6 ASPECTS,
basal ganglia and
ACA regions
0-20 Wei, 2017 [285]
(105)
Acute No NS
28 FLAIR-
MRI,
DWI,
PWI
Hypoperfusion
intensity ration
given by ratio of the
Tmax>10s lesion
over Tmax>6 s
lesion volume
Poor vs good Wouters, 2016 [285]
(141)
Acute No NA
29 3D
multi-
inversion
time
ASL
Regional CBF
on ASL <0.82 as
marker of poor
collaterals
Poor vs good Wu, 2016 [285] (25) Non
acute
Yes, intra-
rater
Pearson-
k=0.871
NA
30 3D
TOF
MRA
Prolongation of
ipsilateral PCA to
the ischaemic side
NA Yamamoto, 2015
[286] (76)
Acute Yes,
kinter=0.92,
kintra=0.91
Beneficial
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Table 2.10: List of outcome parameters most frequently reported to have a correlation
with MR-assessed collaterals and corresponding publications.
Outcome parameter Publications
mRS ≤2 at 3 months 12 papers: [118, 274, 28, 121, 32, 79, 282, 272,
284, 68, 271, 286]
mRS ≤2 at 6 months 1 paper: [280]
Death or discharge to facility other than home 1 paper: [187]
Final infarct volume 3 papers: [122, 118, 284]
Infarct growth 5 papers: [32, 270, 120, 281, 268]
Survival 1 paper: [32]1
HT 1 paper: [79]
Recanalization TICI 2b-3)2 1 paper: [121]
Recanalization TIMI 2-3)2 4 papers: [99, 28, 280, 272]
Early improvement (NIHSS drop 24 h) 1 papers: [28]
Favorable neurological improvement 1 paper: [32]1
NIHSS at 7 days/discharge 2 papers: [280, 28]
Follow-up ASPECTS 3 papers: [280, 28, 284]
Percentage of penumba saved 1 paper: [122]
1Following successful recanalization treatment.
2 Following treatment (either by thrombolysis or mechanical intervention).
Diagnostic/prognostic value of MRI-assessed collaterals
The prognostic value of MRI-assessed collaterals was discussed in 22 publications. 3
of these found no correlation between collaterals and outcome ([277, 283, 284]) while
the remaining ones found correlation with relative and absolute infarct growth,
early neurological improvement, recanalization rate (TIMI score), NIHSS score at
24 h and 7 days, follow-up ASPECTS and long term functional outcome (mRS
at 3 months). The two parameters that were most frequently associated with
collaterals were once again the mRS at 3 months (12 papers) and infarct growth (5
papers).
Among the studies that did not assess the prognostic impact of collaterals, 19
were investigating correlation between other parameters (prognostic value N/A),
while 5 analyzed outcomes but did not state whether there was an association with
MR-assessed collaterals (NS) ([70, 267, 278, 188, 285]).
Better/poorer collaterals assessed with MRI were also correlated with a number of
baseline imaging and clinical parameters (table 2.11). The baseline parameters most
frequently reported to have a correlation with MR-assessed collaterals are baseline
DWI lesion volume (9 papers), PWI lesion volume (5 papers) and PWI/DWI
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Table 2.11: List of baseline parameters most frequently reported to have a correlation
with MR-assessed collaterals and corresponding publications.
Baseline parameter Publications
NIHSS 7 papers: [118, 274, 32, 120, 79, 99, 271]
DWI lesion volume 9 papers: [270, 268, 276, 279, 32, 120, 79, 272, 271]
PWI lesion volume 5 papers: [270, 276, 277, 279, 271]
PWI/DWI ratio 4 papers: [270, 268, 276, 277]
Presence of HV sign 5 papers: [277, 83, 123]∗, [119, 74]∗∗
Blood flow delay on MRP 1paper: [120]
rCBV on PWI 2 papers: [269, 268]
Stroke subtype 1paper: [32]
Cerebrovascular reserve
impairment
1paper: [267]
Onset to treament time 1 paper: [281]
OTHER CORRELATIONS:
Atrial fibrillation ([32]), dehydration ([264]), hyppocampal involvement ([269])
∗Depending on PSE
∗∗Combined with degree of stenosis
volumes ratio (4 papers). Other baseline parameter frequently investigated and
found to be correlated with MR-assessed collaterals were NIHSS score (7 papers)
and the presence of HV sign (5 papers). Once again, one publication reported
correlation between poor collaterals and shorter onset to treatment time ([281]).
Other less frequently observed correlations are listed in table 2.11.
2.4 Discussion
Many studies have established that collaterals can help limit the extent of infarction
prior to the restoration of reperfusion, that good LM collaterals are correlated
with clinical outcome and in particular that they are associated with both smaller
final infarct volume and mRS ≤2 at 3 months. Moreover collaterals have been
correlated to a high number of baseline parameters, such as initial infarct size,
NIHSS, ASPECTS and DWI/PWI mismatch.
Yet, this systematic review highlights how big the inconsistency in the assessment
of LM collaterals still is, with at least 93 different methods reported in literature
and no clear indication that over time the methods are becoming fewer and/or
more standardized.
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Three main imaging modalities are used for collateral assessment: DSA, CTA,
MRI, with DSA and CTA being the most well established. TCD provides little
information about CF and only at the circle of Willis and was found in only one
publication. Although some of the publications reviewed presented assessment
methods applicable to all vascular territories, the majority only looked at anterior
circulation and in particular at MCA occlusions. A huge variety of grading scales
was found, with lower numbers usually denoting bad collaterals and higher numbers
indicating good collaterals, but grading criteria changing from one method to the
other. Despite many scales having >3 grades, a lot of publications then used a
dichotomized or trichotomized classification for the statistical analysis, since the
final goal of the research is often to get a yes/no answer to whether a patient
should be treated in a particular way or not. Less than half of the publications
reported inter and/or intra rater agreement, but when present, the agreement was
almost always good/very good, which makes it problematic to select an optimal
assessment method.
DSA is still considered the gold standard for directly imaging blood vessels and
it actually provides excellent temporal and spatial resolution. However it is time
consuming, invasive and requires expert interventionists to perform it. CT an-
giographies have been proved to have really good specificity and sensitivity for
the detection of proximal large vessel thrombus when compared with DSA, while
requiring at the same time lower doses of contrast, having less risk of vascular
complications and causing less patient discomfort than DSA. Therefore, CTA is
gradually replacing conventional catheter angiography in clinical practice, especially
in acute settings. This shift towards CTA is also aided by the fact that CTA is
more widely available and has shorter scanning times. CTA is less expensive and
easier to interpret also compared to MRA. It can reach acquisition speeds down to
under 1 sec from arch to vertex [25], which is ideal for minimizing misrecording
from breathing artifact and motion. In addition to these advantages, CTA poses
itself as a fast natural extension of non contrast head CT, which in the majority
of the stroke centers is already performed on all patients prior to thrombolytic
treatment to exclude the presence of haemorrhages and large infarcts, which are
contraindications for both thrombolysis and thrombectomy [11]. Thus rapid data
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acquisition and postprocessing make CT-CTA a good candidate for assessment of
collaterals.
CTA however has some limitations. For example, it can not provide information
about flow direction. The capability of determining flow direction is a desirable
feature in optimal imaging protocols for collateral assessment, since it may prevent
from erroneously identifying residual anterograde flow through the occlusion as
collateral flow. Moreover, conventional CTA is typically performed with single
phase protocols which do not provide time resolved information and, although the
time of acquisition with respect to bolus is typically quite accurate, delays in the
arrival of the blood flow in the affected hemisphere may lead to mislabeling of
collaterals.
The actual phase of acquisition of single-phase CTA is a crucial aspect for the correct
interpretation of CTA-based collaterals. However there is disagreement regarding
what is the optimal phase of contrast enhancement for collaterals assessment. It
is generally agreed that the phase of peak arterial enhancement is often optimal
to detect arterial occlusions stenoses and aneurysms, but may fail in capturing
the arrival of delayed collateral contrast material. In line with this thinking, Kim
et al. hypothesized that collaterals may be better assessed in the late venous
phase [32], while Beyer et al. argued that the late venous phase may lead to an
overstimation of collaterals due to concurrent enhancement of the venous vessels.
Beer et al. compared different scoring systems based on both hypoattenuated
volume detection and collateral vessels grading on multi-phase CTA and concluded
that the degree of collateralization offers the best prognostic value when assessed
during the arteriovenous phase rather than the peak arterial or late venous phase
[200].
Some of the limitations of single-phase CTA may be overcome by the use of time-
resolved CT imaging, such as CTP or multiphase CTA. CTP has been successfully
used to assess collaterals and predict good response to intravenous thrombolysis
treatment. However, it has the disadvantage of requiring longer acquisition times,
additional radiation and time consuming post-processing. Moreover there is a lack
of standardization in post-processing tools across vendors and there is no robust
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evidence validating CTP use in identifying the penumbra [45, 287]. Tan et al.
reported that CTA was better than combined CT-CTP for quantifying the degree
of collateral circulation [1]. In this respect multiphase CTA might offer a simpler
solution to the lack of time-resolved information in CTA and to determine flow
direction and phase of contrast enhancement.
MRA is analogous to CTA, offers improved sensitivity and does not generally
involve the use of ionizing radiation. Advanced MR techniques such as arterial spin
labeling, can give quantitative assessment of flow velocity in addition to structural
information. However, MR has the disadvantage of having more contraindications
and longer acquisition times than CTA, which is undesirable in acute settings.
MRA is not as readily available and easy to interpret as CTA. In general, there is a
great potential for improving the feasibility and accuracy of MRI-based techniques
to assess CF, but it is unlikely that MRI images will be obtained with the same
efficiency as CT-based images in the very near future [288]. Moreover, from
this systematic review it emerged that there is a larger variety in the assessment
criteria for MRI-methods than for CT and DSA and the most commonly used
methods consists in the detection of HV sign on FLAIR-MRI whose correlation
with collaterals is still highly debated.
In conclusion, it is well established that collaterals influence the extension and fate
of the ischaemic penumbra and that they may advance development of image-based
treatments. However, assessment methods lack standardization and DSA is still
used as gold-standard despite being invasive and of limited availability. In the
future, noninvasive grading systems will be essential since many stroke patients do
not undergo DSA and ideally even those undergoing endovascular therapy would
be screened first with noninvasive imaging. It seems that time-resolved CT imaging
would be an optimal candidate to replace DSA and provide whole-brain dynamic
angiographic information.
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Chapter 3
Quality of collateral scores on
single-phase CTA
3.1 Introduction
This chapter presents the result of a retrospective study conducted at the Queen
Elizabeth University Hospital in Glasgow. As previously mentioned, the use of
collateral parameters in research clinical trials at the QEUH is still quite limited
and is far from being implemented in the daily clinical practice. However, it is an
objective of the Stroke Unit at the QEUH that collaterals parameter gradually
become a part of routine assessment of stroke patients.
In order to do so, clear guidelines and faster and more reliable tools than currently
available are needed. The low standardization of scoring methods and the increas-
ingly large number of imaging modalities available make it harder to identify the
optimal collateral scoring method, however some considerations can be made that
narrow down the options available.
CT is the imaging modality currently available to all patients at the QEUH. CTP
and/or multi-phase CTA, which provide time-resolved blood flow information, have
the potential of giving more reliable collaterals assessment, but at present they are
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not routinely performed on patients with suspected acute ischaemic stroke at the
QEUH and their implementation in the daily practice would not be as immediate as
for CTA. Baseline single-phase CTA, thanks to the lower costs, shorter acquisition
time, higher availability of experienced staff and easier interpretation than CTP, is
already performed on most stroke patients and is therefore the best candidate for
assessing collateral vessels at the QEUH.
When measuring collaterals on single-phase CTA the timing/phase of acquisition
must be taken into account. Although the automatic triggering of the scanner
generally ensures that the image is acquired in the equilibrium phase, the finite
resolution of the system as well as the unpredictable differences in the circulatory
system of patients undergoing a stroke may cause off-time acquisitions.
With the above in mind, we decided to look at some recent stroke trials conducted
at the QEUH and other centers with which the QEUH Stroke Unit has collaborated
and that included both baseline single-phase CTA and time-resolved CT imaging.
The aim of the study was to, firstly, investigate what the actual phase of contrast
enhancement captured by the single-phase CTA scans is and, secondly, investigate
how collaterals measured on single-phase CTA scans compare with collateral on
time-resolved baseline imaging.
The clinical trials from which the scans were pooled were:
• the Multicentre Acute Stroke Imaging Study (MASIS) [289]
• POst Stroke Hyperglycaemia (POSH) study [290]
• the Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (AT-
TEST) [291]
• low-dose tenecteplase versus standard-does alteplase for acute ischaemic
stroke study (Australian-TNK).
None of the above studies had multi-phase CTA imaging at baseline, however they
had baseline CT perfusion. Therefore, we decided to compare single-phase CTA
collaterals with collaterals measured on temporal MIP derived from CTP.
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3.1.1 Clinical trials
MASIS was a multicentre prospective observational study conducted in Scotland
between 2008 and 2010 and recruited 83 patients. Patients were enrolled if they had
a clinical diagnosis of AIS, presented at <6 hours from symptom onset and were
older than 18. Exclusions criteria included a non-AIS diagnosis prior to recruitment,
inability to lie for the duration of the imaging procedures, intercurrent illness likely
to cause death within 30 days, coma, chronic or acute renal failure and sensitivity
to contrast for CTA or MRI imaging. Baseline imaging included either CT, CTA
and CTP or MRI. The outcome was measured as mRS at 30 and 90 days.
POSH was an observational single-centre study conducted in Glasgow between
2009 and 2011 and recruited 111 patients. Patients were enrolled retrospectively
after receiving routine care for acute stroke if they had undergone baseline CT,
CTP and CTA. The inclusion criteria were a clinical diagnosis of AIS, age over 18
and <6 hours from symptom onset. Exclusion criteria were similar to the MASIS
trial. Clinical outcome was measured as the mRS at 30 days.
The Australian-TNK study was a multicentre study conducted in three Australian
stroke centres between 2008 and 2011 that recruited 75 patients, whereas ATTEST
was a single centre study performed in Glasgow between 2011 and 2013 that
recruited 105 patients.
Both the Australian-TNK and ATTEST trials were prospective, randomized, open-
label, blinded endpoint studies that sought to compare the efficacy and safety
of alteplase and tenecteplase. They recruited patients with supratentorial acute
ischaemic stroke that were eligible for thrombolysis and used clinical and imaging
biomarkers for outcome evaluation. The inclusion criteria were age >18, and time
from symptom onset <4.5 hours for ATTEST and <6 hours for the Australian-
TNK trial. Patients with major early ischaemic change on non-contrast CT were
excluded.
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Table 3.1: Classification of occlusions based on type and/or site of the occlusion.
Occlusion Description
ICA L- or T-shaped occlusion at the ICA-MCA bifurcation
PROX M1 Proximal M1 occlusion, defined as an occlusion in the first 10
mm of the M1 segment of the MCA
DIST M1 Distal M1 occlusion, defined as an occlusiono in the remaining
portion of the M1 segment of the MCA
MCA-M2 Occlusion in the M2 portion of the MCA
PCA Occlusion in the posterior cerebral artery
ACA Occlusion in the anterior cerebral artery
3.2 Materials and methods
3.2.1 Site of occlusion
All the scans were assessed for the presence of occlusions by using the licensed
imaging softare MIStar [292]. The scans were evaluated by looking at maxium
intensty projection of variable thickness (5, 10, 15 and 20 mm). Each occlusion
was classified according to the hemisphere, left or right. Each occlusion was further
scored based on site and type of occlusion according to the classification reported
in table 3.1.
All the scans were scored by consensus of at least two experienced stroke neurologists
or neuroradiologists. Cases from POSH and MASIS were scored by Prof. Keith Muir
(>10 years experience), Dr. Christopher Pollard (∼2 year experience) and Dr. Sin
Yee Foo (∼2 year experience). For the cases of the ATTEST and Australian-TNK
studies, previous scores were available and only scans with reported occlusions were
analyzed. Two raters (K.M. and S.Y.F.) scored the site of occlusions by consensus.
When the score was in disagreement with the previously reported score, the latest
score was retained.
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Table 3.2: CTA-based collateral scoring system proposed by Tan et al. [1].
Score Description
0 Absent collaterals
1 Collaterals filling ≤50% of the occluded territory
2 Collaterals filling >50% but <100% of the occluded territory
3 Collaterals filling 100% of the occluded territory
3.2.2 Assessment of collaterals on single phase CTA
For all the scans that were found to have an occlusion, collaterals were assessed
on single-phase CTA, by looking at MIPs of 20 mm thickness on the MIStar
software. The collateral scores were determined by consensus of two raters (K.M.
and S.Y.F.).
Collaterals were scored according to a method presented by Tan et al. and reported
in table 3.2 [1]. This was selected based on the results of the systematic review
presented in chapter 2 which showed it was the most used scale for assessment of
collaterals on CTA angiography (reported in 54 publications). The raters were
provided with an example image for each score prior to the assessment (figure
3.1).
3.2.3 Assessment of collaterals on tMIP from CTP
For each scan with ICA or MCA occlusion and with baseline CTP available,
collaterals were scored using the scale proposed by Tan (table 3.2) on temporal
MIPs. The processing of CTP scans and analysis of the temporal MIPs was done by
radiologist S.Y.F. using the MIStar software and according to a method proposed
by Smit et al. [182].
For each CTP scan 3 temporal MIPs were derived, corresponding to the arterial,
equilibrium (or arteriovenous) and venous phase. Each temporal MIP was auto-
matically reconstructed by taking for each pixel the the maximal enhancement over
time relative to the selected time interval.
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Figure 3.1: Axial 20-mm images illustrating the collateral scoring methodology proposed
by Tan et al. (source of image: Dehkharghani et al., 2015[7]). The red ROI
indicates a pathologic MCA territory.
For each phase of ecah scan, collaterals were then scored by using again the scale
proposed by Tan et al. (table 3.2). Scores were determined independently by two
radiologists (S.Y.F. and Dr. Amith Sitaram, > 5 years experience) and agreement
was reached by consensus in case of discrepancy.
3.2.4 Phase of acquisition of CTA scans
Each case for which temporal-MIP were reconstructed was then re-examined in
order to determine the phase of acquisition of the single-phase CTA scan. The
phases of scans from the POSH, MASIS and ATTEST studies were determined by
M.G. and the phases of the Australian-TNK were determined by both M.G. and
S.Y.F.
In order to calculate the phase we adopted a procedure proposed by Casault et al.
[2]. The method as presented by Casault involves the following steps:
1. measure the maximum Hounsfield Unit (HU) in the intracranial portion of
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Table 3.3: HU thresholds adopted to determine the phase of image acquisition of con-
ventional (single-phase) CTA. [2].
Phase Arterial HU Venous HU
Early arterial Higher than venous vascula-
ture
≤200
Peak arterial ≥100 higher than venous
vasculature
>200
Equilibrium <100 higher or equal to
venous vasculature
>200
Peak venous >200 Higher than arterial vascula-
ture
Late venous ≤200 Higher than arterial vascula-
ture
the ICA and M1 portion of the MCA and calculate the average to obtain an
arterial score;
2. measure the maximum HU in the sigmoid sinus, torcula and initial portion
superior sagittal sinus and calculate the average to obtain the venous score;
3. compare the arterial and venous score and establish the phase of the scan
based on the threshold reported in table 3.3.
Due to the low number of scans in our study, we chose to adopt a trichotomized
score in our analysis, grouping early arterial and peak arterial into a single arterial
phase and peak venous and late venous into a single venous phase.
In order to locate the maximum HU of the five vasculature territories a volume of
interest (VOI) was manually segmented using the open-platform software 3D Slicer
[293]. 3D Slicer supports user-customized modules and is therefore a very flexible
tool. The choice of using the software was mostly dictated by the fact that it allows
easy export of segmented volumes and various parameters as well as the possibility
of developing Python-based scripts that can be run within the application
Each scan was opened in 3D Slicer and a segmentation was manually created, the
segmentation containing 5 segments, one for each of the five vascular territories
65
3.2 Materials and methods
Figure 3.2: Example view of a scan being analyzed using the custome-written module
in 3D Slicer.
listed above. A custom-written module was then used to automate the remaining
steps. The code of the module is attached in Appendix B and was developed by
using the built-in Scripted Loadable Module Python class provided by 3D Slicer.
The module simply provides user-defined buttons which allow to:
• automatically locate the maximum HU within each segment;
• create a spherical ROI of unitary radius around this point;
• export the coordinates of the point with maximum HU, the volume array data
of the ROI, minimum HU, average HU and maximum HU of each spherical
ROI as a Python pickle object.
Figure 3.2 shows an example view of the custom built module used for the phase
determination in 3D Slicer, with the module interface display in the grey panel on
the left.
From the exported data the maximum HU can then be used to determine the
phase as explained above either by using a simple Python script or in Excel. The
rationale for using the above module was to retain segmentation data such that,
if full automation of the phase calculation via machine learning is pursued in the
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Figure 3.3: Classification of occlusions detected on the baseline CTA scans of the MASIS,
POSH, ATTEST and Australian-TNK studies.
future, the segmented data may be used as training data for the algorithm.
Once the phase of each scan was estimated, CTA-based collateral scores were
compared with the tMIP-based collateral score corresponding to the estimated
phase. Agreement between the two score was assessed as Kappa value (analysis
performed by S.Y. using SPSS [3]). K-values equal to 0.01-0.02 were rated as none
to slight agreement, 0.21-0.40 as fair, 0.41-0.60 as moderate, 0.61-0.80 as substantial
and 0.81-1.00 as almost perfect agreement.
3.3 Results
The total number of cases with baseline CTA retrieved from the 4 studies was 255:
38 from the MASIS study, 55 from the POSH study, 101 from the ATTEST and
61 from the Australian-TNK study. 168 of these were found to have an occlusion.
The distribution of the occlusion site is illustrated in figure 3.3. No cases of ACA
occlusions were detected. The majority of occlusions, as expected, was located in
the MCA-M1 followed by MCA-M2 portion. Table 3.4 summarized the results
of the collaterals assessment on single phase-CTA for each of the 168 cases with
confirmed occlusion.
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Table 3.4: Summary of collateral scores assessed on baseline single-phase CTA divided
by occlusion type. One scan technically inadequate to assess collaterals. One
scan had double occlusion on L/R side and could not be scored.
Score ICA M1 M2 M3 ACA PCA Total1,2
0 3 3 6 - - 1 13
1 5 25 22 - - 1 52
2 9 43 17 - - 1 69
3 - 14 7 5 - 6 32
Figure 3.4: Collaterals grades by imaging modality and by phase.
Reconstruction of temporal MIPs and assessment of the acquisition phase of baseline
CTA was performed only for 41 cases that had either ICA or M1 occlusions and
baseline CTP available. Of these, 17 had baseline single-phase CTA acquired in
arterial phase, 16 in the equilibrium phase and 8 in the venous phase. The collateral
grading betweeen single phase CTA and temporal MIPs in each of the three phase
is summarized in figure 3.4, whereas table 3.5 illustrates the agreement between
collateral scores measured on single-phase CTA and collateral scores measured on
the corresponding temporal MIP image reconstructed from CTP.
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Table 3.5: Overview of the agreement between collateral scores (CS) measured on single-
phase CTA and collateral scores measured on the corresponding tMIP derived
from CTP, subdivided according to the phase of the single-phase CTA acqui-
sitions. In the table, n is the number of cases recorded for each phase and
K is the Kappa value. The numbers on the diagonal correspond to agree-
ment between the two measurements, whereas the numbers off the diagonal
correspond to disagreement [3].
ARTERIAL
n=17
tMIP
CS 0 1 2 3
0 1 1 0 0
C 1 1 2 6 0
T 2 0 1 3 1
A 3 0 0 1 0
K = 0.242
EQUILIBRIUM
n=16
tMIP
CS 0 1 2 3
0 0 0 0 0
C 1 0 3 2 0
T 2 0 0 9 1
A 3 0 0 1 0
K = 0.673
VENOUS
n=8
tMIP
CS 0 1 2 3
0 0 1 0 0
C 1 0 1 0 0
T 2 0 4 0 0
A 3 0 0 2 0
K = 0.2
3.4 Discussion
From the above results and in particular from table 3.5, collateral scores assessed
on single-phase CTA had substantial agreement with collateral score assessed on
temporal MIPs in the equilibrium phase, however they only had fair agreement for
CTA scans acquired in the arterial phase and none to slight agreement in the venous
phase. This suggest that collaterals assessed in the equilibrium (arteriovenous)
phase may be more reliable than collaterals assessed in the other phases. However
more evidence and more cases should be assessed in order to confirm this hypothesis.
CTA alone may not be sufficient to provide a complete assessment of recanalization
(which is best done in arterial phase) and collateral status. A combination of
CT, CTA and CTP or CT and multi-phase CTA would be desirable when the
acquisition phase of the CTA is not known or is not in the equilibrium phase in
order to provide more reliable collateral scores. Nevertheless, single-phase CTA still
provide a valuable tool in assessing collaterals in acute ischaemic stroke, provided
that the phase is assessed and taken into account in the interpretation of the
score.
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The phase assessment method described above to evaluate the actual phase of
acquisition of the single-phase CTA is a time-consuming task and is not a suitable
one for acute ischaemic stroke settings, where time is such as critical factor but future
projects may investigate the development of an automated methods for assessing
the phase and perhaps also for scoring collaterals. The main task in order to achieve
automation would be providing an image processing algorithm, possibly based on
machine learning or other classification techniques, that automatically identifies and
segments the five vascular territories of interest for the phase calculation (ICA, M1,
sigmoid sinus, torcula, superior sagittal sinus). Thereafter, it would be relatively
straightforward to identify the area of maximum enhancement inside each segment
and derive the phase score. This could then develop into being one step of a fully
automated tool for assessment of collateral vessels on CTA, in which an algorithm
determines a collateral score and the phase of the scan and the collateral score is
adjusted by a correcting factor based on the phase of the scan.
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Conclusions
This master thesis was the result of a two year research experience at the Queen
Elizabeth University Hospital in Glasgow.
The bulk of the thesis focused on the discussion of a systematic review of methods
for assessing collaterals in acute ischaemic stroke. The review advances what was
presented in previous reviews and shows that despite the growing acceptance of
collaterals as useful imaging marker, their assessment is not yet standardized and
there are no signs that suggest it will be in the near future.
The second part of the thesis reported the results of a retrospective study to which I
contributed only in part and which sought to investigate the reliability of collaterals
assessed on single-phase CTA as compared to collaterals measured with time-
resolved imaging modalities and, in particular, with temporal-MIP reconstructed
from CT perfusion.
As explained in details in the thesis, the phase of image acquisition in CT angiog-
raphy has an impact on the reliability of the collateral score, since blood flow in
the occluded hemisphere may be slowed down and arrive only when the contrast is
already washed out in the unaffected hemisphere. Therefore, CTA-based collaterals
scoring systems should take into account the phase of the scan and appropriate
corrections should be applied if necessary. Our study showed that when CTA scans
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are acquired in the equilibrium phase there is good agreement with collaterals
score assessed on tMIP from CTP, however when CTA scans are acquired in the
arterial or venous phase, there is only fair agreement. Despite the limited size of
our study, this result may be seen as supporting the hypothesis that collaterals
are best assessed in the arterioenous phase, as suggested by Beyer et al. [200].
However, different studies support a different hypothesis, i.e. that the best phase
for collateral assessment is the late venous phase [32] indicating that there is a
need for further investigation on larger sample sizes.
Although this project did not provide big research advancements, it may provide
the basis for the development of an automated tool for the assessment of collaterals
in acute ischaemic stroke. Automation may be achieved by a machine learning
algorithm or other type of algorithm for which the data presented in the second
part of the thesis may provide training datasets and the results produced by the
systematic literature review may provide valuable information for selecting the best
collateral scoring system.
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Appendix A
Search strategy
Search strategy MEDLINE (1946 to April Week 1 2017) and EMBASE 1996 to
2017 week 17; the number in parenthesis are the results yielded by MEDLINE and
EMBASE respectively:
1. exp Cerebrovascular Disorders/ (321813, 439332)
2. exp brain stem infarctions/ or exp lateral medullary syndrome/ or exp dementia, multiinfarct/
or exp vertebrobasilar insufficiency/ or exp carotidcavernous sinus fistula/ or exp moyamoya
disease/ or exp cerebral small vessel diseases/ or exp cadasil/ or exp cerebral amyloid angiopathy,
familial/ or exp fabry disease/ or exp melas syndrome/ or exp microscopic polyangiitis/ or exp
stroke, lacunar/ or exp cerebrovascular trauma/ or exp carotid artery injuries/ or exp carotid
artery, internal, dissection/ or exp vertebral artery dissection/ or exp dementia, vascular/ or exp
intracranial aneurysm/ or exp intracranial arteriovenous malformations/ or exp "vein of galen
malformations"/ or exp sinus thrombosis, intracranial/ or exp cavernous sinus thrombosis/ or
exp lateral sinus thrombosis/ or exp sagittal sinus thrombosis/ or exp intracranial hemorrhages/
or exp cerebral hemorrhage/ or exp basal ganglia hemorrhage/ or exp putaminal hemorrhage/
or exp cerebral hemorrhage, traumatic/ or exp intracranial hemorrhage, hypertensive/ or exp
intracranial hemorrhage, traumatic/ or exp brain hemorrhage, traumatic/ or exp brain stem
hemorrhage, traumatic/ or exp hematoma, epidural, cranial/ or exp hematoma, subdural/ or exp
hematoma, subdural, acute/ or exp hematoma, subdural, chronic/ or exp hematoma, subdural,
intracranial/ or exp subarachnoid hemorrhage, traumatic/ or exp pituitary apoplexy/ or exp
subarachnoid hemorrhage/ or exp leukomalacia, periventricular/ or exp sneddon syndrome/ or
exp susac syndrome/ or exp vascular headaches/ or exp vasculitis, central nervous system/ or exp
aids arteritis, central nervous system/ or exp giant cell arteritis/ or exp lupus vasculitis, central
nervous system/ or exp vasospasm, intracranial/ (123210, 550204)
3. 1 not 2 (198697, 0)
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4. exp Cerebrovascular Circulation/ (51286, 12269)
5. exp Cerebral Arteries/ (25086, 42851)
6. exp Arterial Occlusive Diseases/ (212912, 119518)
7. exp peripheral arterial disease/ or exp intermittent claudication/ or exp mesenteric vascular
occlusion/ or exp moyamoya disease/ or exp renal artery obstruction/ or exp susac syndrome/
or exp stenosis, pulmonary artery/ or exp thromboangiitis obliterans/ (31985, 124189)
8. 6 not 7 (180927, 0)
9. exp Thrombosis/ (119951, 240323)
10. exp venous thrombosis/ or exp buddchiari syndrome/ or exp postthrombotic syndrome/ or exp
retinal vein occlusion/ or exp thrombophlebitis/ or exp lemierre syndrome/ or exp upper extrem-
ity deep vein thrombosis/ (50773, 101200)
11. 9 not 10 (69178, 146123)
12. exp Constriction, Pathologic/ (28002, 397695)
13. 3 or 4 or 5 or 8 or 11 or 12 (486706, 554907)
14. (“stroke*” or “infarction*, brain” or “brain infarction*”).mp (217311, 330753)
15. ("anterior cerebral circulation* infarction*" or "anterior circulation* brain infarction*" or "anterior
circulation* infarction*, brain" or "brain infarction*, anterior circulation*" or "infarction*, ante-
rior cerebral circulation*" or "infarction*, anterior cerebral circulation*, brain" or "infarction*,
brain, anterior circulation*").mp (3, 6)
16. ("posterior cerebral circulation* infarction*" or "posterior circulation* brain infarction*" or "pos-
terior circulation* infarction*, brain" or "brain infarction*, posterior circulation*" or "infarction*,
posterior cerebral circulation*" or "infarction*, posterior cerebral circulation*, brain" or "infarc-
tion*, brain, posterior circulation*").mp (2, 3)
17. ("cerebrovascular accident*" or "accident*, cerebrovascular" or "cerebrovascular apoplex*" or
"apoplex*, cerebrovascular" or "brain vascular accident*" or "vascular accident*, brain" or "cva").mp
(6942, 164172)
18. ("cerebral infarction*" or "infarction*, cerebral" or "subcortical infarction*" or "infarction*, sub-
cortical" or "anterior choroidal arter* infarction*" or "posterior choroidal arter* infarction*").mp
(26832, 15669)
19. ("brain isch?emia*" or "isch?emic attack*" or "cerebral isch?emia*" or "encephalopath*, isch?emic"
or "isch?emic encephalopath*" or "isch?emia*, brain" or "isch?emia*, cerebral" or "attack*, tran-
sient isch?emic" or "brain tia*" or "isch?emia*, transient cerebral" or "tia* transient isch?emic
attack*" or "tia*, brain").mp (79208, 133095)
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20. ("brain vascular disorder*" or "brain vascular disease*" or "cerebrovascular disease*" or "cere-
brovascular disorder*" or "cerebrovascular insufficienc*" or "cerebrovascular occlusion*" or "dis-
ease*, cerebrovascular" or "insufficienc*, cerebrovascular" or "intracranial vascular disease*" or
"intracranial vascular disorder*" or "occlusion*, cerebrovascular" or "vascular disease*, intracra-
nial" or "vascular disorder*, intracranial" or "vascular disorder*, brain" or "vascular disease*,
brain").mp (57210, 51761)
21. ("cerebrovascular circulation*" or "blood flow*, cerebral" or "cerebral blood flow*" or "cerebral
circulation*" or "cerebral perfusion pressure*" or "circulation*, cerebral" or "circulation*, cere-
brovascular" or "flow*, cerebral blood" or "perfusion pressure*, cerebral" or "pressure*, cerebral
perfusion").mp (62395, 30662)
22. ("cerebral arter*" or "arter*, cerebral").mp (50991, 52469)
23. ("arter* narrowing*, carotid" or "arter* plaque*, carotid" or "arter* stenos*s, carotid" or "carotid
arter* narrowing*" or "carotid arter* plaque*" or "carotid arter* stenos*s" or "carotid stenos*s" or
"narrowing*, carotid arter*" or "plaque*, carotid arter*" or "stenos*s, carotid arter*").mp (16822,
13034)
24. ("carotid arter* thrombos*s" or "carotid thrombos*s" or "thrombos*s, carotid").mp (3294, 1558)
25. ("carotid arter* disease*" or "arter*disease*, carotid" or "arter* disease*, carotid" or "arter* disor-
der*, carotid" or "atherosclerotic disease*, carotid" or "carotid arter* disease*" or "carotid arter*
disorder*" or "carotid atheroscleros*s" or "carotid atherosclerotic disease*" or "disorder*, carotid
arter*").mp (22943, 15132)
26. ("arter* occlusive disease*" or "arter* obstructive disease*" or "disease*, arter* obstructive" or
"disease*, arter* occlusive" or "occlusive disease*, arter*" or "obstructive disease*, arter*").mp
(28694, 4407)
27. ("brain thrombos*s" or "brain thrombus" or "cerebral thrombos*s" or "cerebral thrombus" or
"intracranial thrombos*s" or "intracranial thrombus" or "thrombos*s, brain" or "thrombos*s ,
cerebral" or "thrombos*s, intracranial" or "thrombus, brain" or "thrombus, cerebral" or "thrombus,
intracranial").mp (5503, 830)
28. ("constriction* pathologic*" or "pathologic* constriction*" or "stenos*s" or "occlusion*").mp (317108,
334431)
29. ("infarction*, mca" or "embolus, mca" or "mca infarction*" or "mca circulation infarction*" or
"mca embolic infarction*" or "mca embolus" or "mca infarction*" or "mca syndrome" or "mca
thrombos*s" or "mca thrombotic infarction*" or "thrombos*s, mca" or "thrombotic infarction*,
mca").mp (296, 513)
30. ("infarction*, middle cerebral arter*" or "embolus, middle cerebral arter*" or "middle cerebral
arter* infarction*" or "middle cerebral arter* circulation infarction*" or "middle cerebral arter*
embolic infarction*" or "middle cerebral arter* embolus" or "middle cerebral arter* infarction*"
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or "middle cerebral arter* syndrome" or "middle cerebral arter* thrombos*s" or "middle cerebral
arter* thrombotic infarction*" or "thrombos*s, middle cerebral arter*" or "thrombotic infarction*,
middle cerebral arter*").mp (7192, 850)
31. ("infarction*, anterior cerebral arter*" or "embolus, anterior cerebral arter*" or "anterior cere-
bral arter* infarction*" or "anterior cerebral arter* circulation infarction*" or "anterior cerebral
arter* embolic infarction*" or "anterior cerebral arter* embolus" or "anterior cerebral arter* infarc-
tion*" or "anterior cerebral arter* syndrome" or "anterior cerebral arter* thrombos*s" or "anterior
cerebral arter* thrombotic infarction*" or "thrombos*s, anterior cerebral arter*" or "thrombotic
infarction*, anterior cerebral arter*").mp (239, 52)
32. ("infarction*, posterior cerebral arter*" or "embolus, posterior cerebral arter*" or "posterior cere-
bral arter* infarction*" or "posterior cerebral arter* circulation infarction*" or "posterior cerebral
arter* embolic infarction*" or "posterior cerebral arter* embolus" or "posterior cerebral arter*
infarction*" or "posterior cerebral arter* syndrome" or "posterior cerebral arter* thrombos*s" or
"posterior cerebral arter* thrombotic infarction*" or "thrombos*s, posterior cerebral arter*" or
"thrombotic infarction*, posterior cerebral arter*").mp (291, 84)
33. ("infarction*, ica" or "embolus, ica" or "ica infarction*" or "ica circulation infarction*" or "ica
embolic infarction*" or "ica embolus" or "ica infarction*" or "ica syndrome" or "ica thrombos*s"
or "ica thrombotic infarction*" or "thrombos*s, ica" or "thrombotic infarction*, ica").mp (20, 30)
34. ("infarction*, pca" or "embolus, pca" or "pca infarction*" or "pca circulation infarction*" or "pca
embolic infarction*" or "pca embolus" or "pca infarction*" or "pca syndrome" or "pca thrombos*s"
or "pca thrombotic infarction*" or "thrombos*s, pca" or "thrombotic infarction*, pca").mp (37,
63)
35. 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30
or 31 or 32 or 33 or 34 (675192, 758815)
36. 13 or 35 (845031, 1003439)
37. exp treatment outcome/ or exp response evaluation criteria in solid tumors/ or exp sustained viro-
logic response/ or exp treatment failure/ or exp failure to rescue, health care/ (833128, 1245612)
38. exp response evaluation criteria in solid tumors/ or exp sustained virologic response/ (206, 1658)
39. 37 not 38 (832922, 1243954)
40. ("clinical outcome*" or "clinical effectiveness*" or "clinical efficacy" or "effectiveness*, clinical" or
"efficacy, clinical" or "efficacy, treatment*" or "outcome*, treatment*" or "treatment*, effective-
ness*" or "treatment* efficacy" or "treatment* outcome*").mp (920747, 1024796)
41. 39 or 40 (946087, 1472877)
42. 36 or 41 (1699411, 2317735)
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43. exp Angiography/ (223904, 257778)
44. exp Magnetic Resonance Imaging/ (374612, 712411)
45. exp Tomography, XRay Computed/ (368009, 697158)
46. exp Ultrasonography, Doppler, Transcranial/ (6652, 466)
47. exp Contrast Media/ (106962, 119980)
48. ("angiograph*" or "arteriograph*" or "angiogram*").mp (265017, 254260)
49. ("magnetic resonance imaging" or "MR imaging" or "diffusion magnetic resonance" or "diffusion
MR*" or "MR* diffusion weighted" or "magnetic resonance diffusion weighted" or "nuclear MRI"
or "nuclear magnetic resonance imaging").mp (401710, 680466)
50. ("CT perfusion," or "comput* tomograph* perfusion" or "transmission comput* tomograph*" or
"transmission CT").mp (1654, 3215)
51. ("xray* comput* tomograph*" or "xray* CT" or "x ray* comput* tomograph*" or "x ray CT").mp
(4347, 8403)
52. ("tomograph*, xray* comput*" or "xray* tomograph*, comput*" or "comput* tomograph*, xray*"
or "xray*, comput* tomograph*" or "comput*, xray* tomograph*" or "tomograph*, xray* com-
put*").mp (341442, 9963)
53. (“doppler transcranial *sonograph*" or "doppler *sonograph*, transcranial" or "*sonograph*,
doppler transcranial" or "*sonograph*, transcranial doppler" or "transcranial doppler *sonograph*"
or "transcranial *sonograph*, doppler").mp (1300, 1463)
54. “neurosonolog*".mp (162, 439)
55. (“contrast media" or "*contrast agent*" or "contrast material*").mp (90262, 41328)
56. 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 (994629, 1453919)
57. exp Cerebral Arteries/ (25086, 42851)
58. exp Cerebrovascular Circulation/ (51286, 12269)
59. exp Collateral Circulation/ (11720, 8316)
60. ("arteries, cerebral" or "artery, cerebral" or "cerebral arteries" or "cerebral artery").mp. (45095,
48771)
61. ("blood flow*, cerebral" or "cerebral blood flow*" or "cerebral circulation*" or "cerebral perfu-
sion pressure*" or "cerebrovascular circulation*" or "circulation*, cerebral" or "circulation*, cere-
brovascular" or "flow*, cerebral blood" or "perfusion pressure*, cerebral" or "pressure*, cerebral
perfusion").mp (62395, 30662)
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62. ("collateral circulation*" or "blood circulation*, collateral" or "blood collateral circulation*" or
"circulation*, blood collateral" or "circulation*, collateral blood" or "circulation collateral" or
"collateral blood circulation*" or "collateral circulation*, blood").mp (13932, 9939)
63. ("leptomeningeal collateral*" or "leptomeningeal vessel*" or "pial collateral*" or "pial vessel*").mp
(763, 837)
64. ("collateral flow" or "collateral flows" or "collateral blood supply" or "collateral blood supplies").mp
(2176, 2137)
65. ("collateral" or "collaterals").tw (33085, 30496)
66. ("recanali?ation" or "recanali? ation" or "recanali?e" or "recanali? e").mp (9229, 20476)
67. 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 (143189, 137630)
68. 42 and 56 and 67 (40226, 51456)
69. exp adult/ or exp aged/ or exp "aged, 80 and over"/ or exp frail elderly/ or exp middle aged/ or
exp young adult/ (6410596, 4999208)
70. (adult* or aged or elderl*).mp (6980874, 5467682)
71. 69 or 70 (6980874, 5467710)
72. 68 and 71 (27985, 29940)
73. limit 72 to (english language and yr=“2009 Current”) (9357, 16487)
74. limit 73 to animals (152, 288)
75. limit 74 to humans (59, 0)
76. 74 and 75 (59, 0)
77. 74 not 76 (93, 288)
78. 73 not 77 (9264, 16199)
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Appendix B
3D Slicer Module
1 import os
2 import vtk, qt, ctk, slicer
3 from slicer.ScriptedLoadableModule import *
4 import unittest
5 import logging
6 import numpy as np
7 import pickle as pkl
8 import SegmentStatistics
9 from pprint import pprint
10
11 dir = os.path.dirname(__file__)
12 exp_folder = os.path.join(dir, "../../../phase_HU/")
13
14 #
15 # CTA_phase
16 #
17 class CTA_phase(ScriptedLoadableModule):
18 """Uses ScriptedLoadableModule base class"""
19
20 def __init__(self, parent):
21 ScriptedLoadableModule.__init__(self, parent)
22 self.parent.title = "CTA_phase"
23 self.parent.categories = ["Stroke"]
24 self.parent.dependencies = []
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25 self.parent.contributors = [
26 "Marta()"]
27 self.parent.helpText = """
28 For estimation of phase in CTA scans.)"""
29 self.parent.acknowledgementText = """ """
30
31 #
32 # CTA_phaseWidget
33 #
34 class CTA_phaseWidget(ScriptedLoadableModuleWidget):
35 """Uses ScriptedLoadableModuleWidget base class"""
36
37 def __init__(self, parent):
38 ScriptedLoadableModuleWidget.__init__(self, parent)
39
40 def setup(self):
41 ScriptedLoadableModuleWidget.setup(self)
42
43 self.grayscaleNode = None
44
45 # Instantiate and connect widgets ...
46
47 #
48 # Layout buttons
49 #
50 layoutsButton = ctk.ctkCollapsibleButton()
51 layoutsButton.text = "Layouts"
52 self.layout.addWidget(layoutsButton)
53 layoutsFormLayout = qt.QGridLayout(layoutsButton)
54
55 self.tabbedSliceButton= qt.QPushButton("Tabbed Slice")
56 self.tabbedSliceButton.toolTip = "Show Tabbed Slice layout "
57 self.tabbedSliceButton.enabled = True
58 layoutsFormLayout.addWidget(self.tabbedSliceButton, 0, 0)
59
60 self.fourUpButton= qt.QPushButton("Four up")
61 self.fourUpButton.toolTip = "Show Four Up Layout "
62 self.fourUpButton.enabled = True
63 layoutsFormLayout.addWidget(self.fourUpButton, 0, 1)
80
64
65 selectPatientCollapsibleButton = ctk.ctkCollapsibleButton()
66 selectPatientCollapsibleButton.text = "Select patient"
67 self.layout.addWidget(selectPatientCollapsibleButton)
68 selectPatientFormLayout = qt.QGridLayout(selectPatientCollapsibleButton)
69
70 #
71 # Patient Number Button
72 #
73 self.patientNumberButtonLabel = qt.QLabel("Show all patients in
database")
74 self.patientNumberButton= qt.QPushButton("Show")
75 self.patientNumberButton.toolTip = "Prints patient numbers in your
Slicer DICOM database"
76 self.patientNumberButton.enabled = True
77 selectPatientFormLayout.addWidget(self.patientNumberButtonLabel, 0, 0)
78 selectPatientFormLayout.addWidget(self.patientNumberButton, 0, 1)
79
80 self.patientSpinBoxLabel = qt.QLabel("Set patient number")
81 self.patientSpinBox = qt.QSpinBox()
82 self.patientSpinBox.setToolTip("Set number of patient under study")
83 self.patientSpinBox.setMinimum(0)
84 self.patientSpinBox.setMaximum(vtk.VTK_INT_MAX)
85 self.patientSpinBox.setValue(0)
86 selectPatientFormLayout.addWidget(self.patientSpinBoxLabel, 1, 0)
87 selectPatientFormLayout.addWidget(self.patientSpinBox, 1, 1)
88
89 #
90 # Parameters Area
91 #
92 parametersCollapsibleButton = ctk.ctkCollapsibleButton()
93 parametersCollapsibleButton.text = "Parameters"
94 self.layout.addWidget(parametersCollapsibleButton)
95 # Layout within the dummy collapsible button
96 self.parametersFormLayout = qt.QFormLayout(parametersCollapsibleButton)
97
98 #
99 # input volume selector
100 #
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101 self.inputSelector = slicer.qMRMLNodeComboBox()
102 self.inputSelector.nodeTypes = ["vtkMRMLScalarVolumeNode"]
103 self.inputSelector.selectNodeUponCreation = True
104 self.inputSelector.addEnabled = False
105 self.inputSelector.removeEnabled = False
106 self.inputSelector.noneEnabled = False
107 self.inputSelector.showHidden = False
108 self.inputSelector.showChildNodeTypes = False
109 self.inputSelector.setMRMLScene( slicer.mrmlScene )
110 self.inputSelector.setToolTip( "Pick the input to the algorithm." )
111 self.parametersFormLayout.addRow("Input Volume: ", self.inputSelector)
112
113 #
114 # Slab thickness value
115 #
116 self.slabThicknessSliderWidget = ctk.ctkSliderWidget()
117 self.slabThicknessSliderWidget.singleStep = 1
118 self.slabThicknessSliderWidget.minimum = 1
119 self.slabThicknessSliderWidget.maximum = 100
120 self.slabThicknessSliderWidget.value = 5
121 self.slabThicknessSliderWidget.setToolTip("Set slab thickness value for
computing MIP.")
122 self.parametersFormLayout.addRow("Slab thickness [mm]",
self.slabThicknessSliderWidget)
123
124 #
125 # Slab slice spacing
126 #
127 self.slabSliceSpacingSliderWidget = ctk.ctkSliderWidget()
128 self.slabSliceSpacingSliderWidget.singleStep = 0.5
129 self.slabSliceSpacingSliderWidget.minimum = 0.5
130 self.slabSliceSpacingSliderWidget.maximum = 10
131 self.slabSliceSpacingSliderWidget.value = 1
132 self.slabSliceSpacingSliderWidget.setToolTip("Set slab slice spacing
value for slice viewers.")
133 self.parametersFormLayout.addRow("Slice Spacing [mm]",
self.slabSliceSpacingSliderWidget)
134
135 #
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136 # Show MIP Button
137 #
138 self.showMIPRedButton = qt.QPushButton("MIP Red")
139 self.showMIPRedButton.toolTip = "Show MIP in red viewer"
140 self.showMIPRedButton.enabled = False
141 self.parametersFormLayout.addRow(self.showMIPRedButton)
142
143 self.showMIPYellowButton = qt.QPushButton("MIP Yellow")
144 self.showMIPYellowButton.toolTip = "Show MIP in yellow viewer"
145 self.showMIPYellowButton.enabled = False
146 self.parametersFormLayout.addRow(self.showMIPYellowButton)
147
148 self.showMIPGreenButton = qt.QPushButton("MIP Green")
149 self.showMIPGreenButton.toolTip = "Show MIP in green viewer"
150 self.showMIPGreenButton.enabled = False
151 self.parametersFormLayout.addRow(self.showMIPGreenButton)
152
153 #
154 # Window level value
155 #
156 self.windowLevelSliderWidget = ctk.ctkSliderWidget()
157 self.windowLevelSliderWidget.singleStep = 10
158 self.windowLevelSliderWidget.minimum = -1000
159 self.windowLevelSliderWidget.maximum = 1000
160 self.windowLevelSliderWidget.value = 150
161 self.windowLevelSliderWidget.setToolTip("Set window level (HU).")
162 self.parametersFormLayout.addRow("Window level (HU)",
self.windowLevelSliderWidget)
163
164 #
165 # Window Width value
166 #
167 self.windowWidthSliderWidget = ctk.ctkSliderWidget()
168 self.windowWidthSliderWidget.singleStep = 20
169 self.windowWidthSliderWidget.minimum = 20
170 self.windowWidthSliderWidget.maximum = 2000
171 self.windowWidthSliderWidget.value = 400
172 self.windowWidthSliderWidget.setToolTip("Set window width (HU).")
173 self.parametersFormLayout.addRow("Window width (HU)",
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self.windowWidthSliderWidget)
174
175 #
176 # windowSettings Button
177 #
178 self.windowSettingsButton = qt.QPushButton("Set window level and width")
179 self.windowSettingsButton.toolTip = "Set window level and width. Fine
adjustment with mouse."
180 self.windowSettingsButton.enabled = False
181 self.parametersFormLayout.addRow(self.windowSettingsButton)
182
183 self.getWinSettButton = qt.QPushButton(’Show window settings’)
184 self.getWinSettButton.toolTip = ""
185 self.getWinSettButton.enabled = True
186 self.parametersFormLayout.addRow(self.getWinSettButton)
187
188 #
189 # Add vertical spacer
190 #
191 self.layout.addStretch(1)
192
193 #
194 # Phase Arena
195 #
196 phaseCollapsibleButton = ctk.ctkCollapsibleButton()
197 phaseCollapsibleButton.text = "Phase"
198 self.layout.addWidget(phaseCollapsibleButton)
199 # Layout within the dummy collapsible button
200 phaseFormLayout = qt.QGridLayout(phaseCollapsibleButton)
201
202 #
203 # Fiducials list
204 #
205
206 #Display all fiducial points
207
208 # Set the 4 points
209 self.pOneSpinBoxLabel = qt.QLabel("ICA")
210 self.pOneSpinBox = qt.QSpinBox()
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211 self.pOneSpinBox.setToolTip("Fiducial point in ICA")
212 self.pOneSpinBox.setMinimum(0)
213 self.pOneSpinBox.setMaximum(vtk.VTK_INT_MAX)
214 self.pOneSpinBox.setValue(1)
215 phaseFormLayout.addWidget(self.pOneSpinBoxLabel, 0, 0)
216 phaseFormLayout.addWidget(self.pOneSpinBox, 0, 1)
217
218 self.pTwoSpinBoxLabel = qt.QLabel("MCA-M1")
219 self.pTwoSpinBox = qt.QSpinBox()
220 self.pTwoSpinBox.setToolTip("Fiducial point in MCA-M1")
221 self.pTwoSpinBox.setMinimum(0)
222 self.pTwoSpinBox.setMaximum(vtk.VTK_INT_MAX)
223 self.pTwoSpinBox.setValue(2)
224 phaseFormLayout.addWidget(self.pTwoSpinBoxLabel, 0, 2)
225 phaseFormLayout.addWidget(self.pTwoSpinBox, 0, 3)
226
227 self.pThreeSpinBoxLabel = qt.QLabel("Sigmoid")
228 self.pThreeSpinBox = qt.QSpinBox()
229 self.pThreeSpinBox.setToolTip("Fiducial point in sigmoid sinus")
230 self.pThreeSpinBox.setMinimum(0)
231 self.pThreeSpinBox.setMaximum(vtk.VTK_INT_MAX)
232 self.pThreeSpinBox.setValue(3)
233 phaseFormLayout.addWidget(self.pThreeSpinBoxLabel, 1, 0)
234 phaseFormLayout.addWidget(self.pThreeSpinBox, 1, 1)
235
236 self.pFourSpinBoxLabel = qt.QLabel("Torcula")
237 self.pFourSpinBox = qt.QSpinBox()
238 self.pFourSpinBox.setToolTip("Fiducial point in sigmoid torcula")
239 self.pFourSpinBox.setMinimum(0)
240 self.pFourSpinBox.setMaximum(vtk.VTK_INT_MAX)
241 self.pFourSpinBox.setValue(4)
242 phaseFormLayout.addWidget(self.pFourSpinBoxLabel, 1, 2)
243 phaseFormLayout.addWidget(self.pFourSpinBox, 1, 3)
244
245 self.pFiveSpinBoxLabel = qt.QLabel("Sup Sag S")
246 self.pFiveSpinBox = qt.QSpinBox()
247 self.pFiveSpinBox.setToolTip("Superior sagittal sinus")
248 self.pFiveSpinBox.setMinimum(0)
249 self.pFiveSpinBox.setMaximum(vtk.VTK_INT_MAX)
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250 self.pFiveSpinBox.setValue(5)
251 phaseFormLayout.addWidget(self.pFiveSpinBoxLabel, 2, 0)
252 phaseFormLayout.addWidget(self.pFiveSpinBox, 2, 1)
253
254 self.radiusSpinBoxLabel = qt.QLabel("Radius of seed")
255 self.radiusSpinBox = qt.QSpinBox()
256 self.radiusSpinBox.setToolTip("Set radius of seed")
257 self.radiusSpinBox.setMinimum(0)
258 self.radiusSpinBox.setMaximum(vtk.VTK_INT_MAX)
259 self.radiusSpinBox.setValue(1)
260 phaseFormLayout.addWidget(self.radiusSpinBoxLabel, 2, 2)
261 phaseFormLayout.addWidget(self.radiusSpinBox, 2, 3)
262
263 self.listFiducialsButton= qt.QPushButton("List points")
264 self.listFiducialsButton.toolTip = "Prints all fiducial points in the
terminal"
265 self.listFiducialsButton.enabled = True
266 phaseFormLayout.addWidget(self.listFiducialsButton, 3, 1)
267
268 self.getPhaseButton= qt.QPushButton("Get phase")
269 self.getPhaseButton.toolTip = "Prints all fiudcial points in the
terminal"
270 self.getPhaseButton.enabled = True
271 phaseFormLayout.addWidget(self.getPhaseButton, 3, 3)
272
273 # Output table selector
274 outputCollapsibleButton = ctk.ctkCollapsibleButton()
275 outputCollapsibleButton.text = "Output"
276 self.layout.addWidget(outputCollapsibleButton)
277 outputFormLayout = qt.QFormLayout(outputCollapsibleButton)
278
279 self.outputTableSelector = slicer.qMRMLNodeComboBox()
280 self.outputTableSelector.nodeTypes = ["vtkMRMLTableNode"]
281 self.outputTableSelector.addEnabled = True
282 self.outputTableSelector.selectNodeUponCreation = True
283 self.outputTableSelector.renameEnabled = True
284 self.outputTableSelector.removeEnabled = True
285 self.outputTableSelector.noneEnabled = False
286 self.outputTableSelector.setMRMLScene( slicer.mrmlScene )
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287 self.outputTableSelector.setToolTip( "Select the table where statistics
will be saved into")
288 outputFormLayout.addRow("Output table:", self.outputTableSelector)
289
290 #
291 # Add vertical spacer
292 #
293 self.layout.addStretch(1)
294
295 #
296 # Reset view to default Button
297 #
298 self.undoMIPButton = qt.QPushButton("Default view")
299 self.undoMIPButton.toolTip = "Reset view to default mode"
300 self.undoMIPButton.enabled = False
301 self.layout.addWidget(self.undoMIPButton)
302
303 #
304 # Reset Scene Button
305 #
306 self.clearSceneButton = qt.QPushButton("Clear scene")
307 self.clearSceneButton.toolTip = "Clear the mrml scene"
308 self.clearSceneButton.enabled = True
309 self.layout.addWidget(self.clearSceneButton)
310
311 #
312 # Connections
313 #
314 self.showMIPRedButton.connect(’clicked(bool)’, self.onShowMIPRedButton)
315 self.showMIPYellowButton.connect(’clicked(bool)’,
self.onShowMIPYellowButton)
316 self.showMIPGreenButton.connect(’clicked(bool)’,
self.onShowMIPGreenButton)
317
318 self.getWinSettButton.connect(’clicked(bool)’, self.onGetWinSettButton)
319 self.windowSettingsButton.connect(’clicked(bool)’,
self.onWindowSettingsButton)
320 self.inputSelector.connect("currentNodeChanged(vtkMRMLNode*)",
self.onSelect)
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321 self.patientNumberButton.connect(’clicked(bool)’,
self.onPatientNumberButton)
322 self.tabbedSliceButton.connect(’clicked(bool)’,
self.onTabbedSliceButton)
323 self.fourUpButton.connect(’clicked(bool)’, self.onFourUpButton)
324 self.listFiducialsButton.connect(’clicked(bool)’,
self.onListFiducialsButton)
325 self.getPhaseButton.connect(’clicked(bool)’, self.onGetPhaseButton)
326 self.undoMIPButton.connect(’clicked(bool)’, self.onUndoMIPButton)
327 self.clearSceneButton.connect(’clicked(bool)’, self.onClearSceneButton)
328
329 #
330 # Add vertical spacer
331 #
332 self.layout.addStretch(2)
333
334 # Refresh drawMidLine button state
335 self.onSelect()
336
337 def onSelect(self):
338 self.showMIPRedButton.enabled = self.inputSelector.currentNode()
339 self.showMIPYellowButton.enabled = self.inputSelector.currentNode()
340 self.showMIPGreenButton.enabled = self.inputSelector.currentNode()
341
342 self.windowSettingsButton.enabled = self.inputSelector.currentNode()
343 self.listFiducialsButton.enabled = self.inputSelector.currentNode()
344 self.undoMIPButton.enabled = self.inputSelector.currentNode()
345
346 def onPatientNumberButton(self):
347 logic = CTA_phaseLogic()
348 logic.showPatientNumbers()
349
350 def onTabbedSliceButton(self):
351 logic = CTA_phaseLogic()
352 logic.selTabbedSliceLayout()
353
354 def onFourUpButton(self):
355 logic = CTA_phaseLogic()
356 logic.selFourUpLayout()
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357
358 def onShowMIPRedButton(self):
359 logic = CTA_phaseLogic()
360 patientNumber = self.patientSpinBox.value
361 slabThickness = self.slabThicknessSliderWidget.value
362 slabSliceSpacingFraction = self.slabSliceSpacingSliderWidget.value
363 logic.showMIPRed(self.inputSelector.currentNode(), slabThickness,
slabSliceSpacingFraction, patientNumber)
364
365 def onShowMIPYellowButton(self):
366 logic = CTA_phaseLogic()
367 patientNumber = self.patientSpinBox.value
368 slabThickness = self.slabThicknessSliderWidget.value
369 slabSliceSpacingFraction = self.slabSliceSpacingSliderWidget.value
370 logic.showMIPYellow(self.inputSelector.currentNode(), slabThickness,
slabSliceSpacingFraction, patientNumber)
371
372 def onShowMIPGreenButton(self):
373 logic = CTA_phaseLogic()
374 patientNumber = self.patientSpinBox.value
375 slabThickness = self.slabThicknessSliderWidget.value
376 slabSliceSpacingFraction = self.slabSliceSpacingSliderWidget.value
377 logic.showMIPGreen(self.inputSelector.currentNode(), slabThickness,
slabSliceSpacingFraction, patientNumber)
378
379 def onWindowSettingsButton(self):
380 logic = CTA_phaseLogic()
381 windowWidth = self.windowWidthSliderWidget.value
382 windowLevel = self.windowLevelSliderWidget.value
383 logic.windowSettings(self.inputSelector.currentNode(), windowWidth,
windowLevel)
384
385 def onGetWinSettButton(self):
386 logic = CTA_phaseLogic()
387 logic.getWindowSettings()
388
389 def onListFiducialsButton(self):
390 logic = CTA_phaseLogic()
391 logic.listFiducials(self.inputSelector.currentNode())
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392
393 def onGetPhaseButton(self):
394
395 # Lock GUI
396 self.getPhaseButton.text = "Working..."
397 self.getPhaseButton.setEnabled(False)
398 slicer.app.processEvents()
399
400 logic = CTA_phaseLogic()
401
402 patientNumber = self.patientSpinBox.value
403 p1 = self.pOneSpinBox.value - 1
404 p2 = self.pTwoSpinBox.value - 1
405 p3 = self.pThreeSpinBox.value - 1
406 p4 = self.pFourSpinBox.value - 1
407 p5 = self.pFiveSpinBox.value - 1
408
409 radius = self.radiusSpinBox.value
410 logic.getPhase(self.inputSelector.currentNode(), patientNumber, p1, p2,
p3, p4, p5, radius)
411
412 # Unlock GUI
413 self.getPhaseButton.setEnabled(True)
414 self.getPhaseButton.text = "Get phase"
415
416 def onUndoMIPButton(self):
417 logic = CTA_phaseLogic()
418 logic.MIPreset()
419
420 def onClearSceneButton(self):
421 slicer.mrmlScene.Clear(0)
422 CTA_phaseLogic().MIPreset()
423
424 #
425 # CTA_phaseLogic
426 #
427 class CTA_phaseLogic(ScriptedLoadableModuleLogic):
428 """This class should implements all the actual
429 computation done by the module."""
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430
431 def selTabbedSliceLayout(self):
432 layoutManager = slicer.app.layoutManager()
433 layoutManager.setLayout(slicer.vtkMRMLLayoutNode.SlicerLayoutTabbedSliceView)
434
435 def selFourUpLayout(self):
436 layoutManager = slicer.app.layoutManager()
437 layoutManager.setLayout(slicer.vtkMRMLLayoutNode.SlicerLayoutFourUpView)
438
439 def showPatientNumbers(self):
440 # Print list of all patients in Slicer DICOM database so the user can
see the number of each patient to access
441 # metadata
442 self.db = slicer.dicomDatabase
443 self.patientList = self.db.patients()
444 for i in range(len(self.patientList)):
445 patientID = self.getPatientID(i)
446 print ’PatientID’, ’=’, patientID, ’ -> Patient N.=’, i
447 return
448
449 def getPatientID(self, patientNumber):
450 # Get patientID from metadata for a given patient in Slicer DICOM
database
451 database = slicer.dicomDatabase
452 patList = database.patients()
453 stList = database.studiesForPatient(patList[patientNumber])
454 serList = database.seriesForStudy(stList[0])
455 flList = database.filesForSeries(serList[0])
456 patID = database.fileValue(flList[0], ’0010,0020’)
457 return patID
458
459 def getSliceThicknessAndSpacing(self, patientNumber):
460 """Get slice spacing and thickness from metadata in DICOM database for
a given patient in Slicer DICOM database
461 """
462 self.db = slicer.dicomDatabase
463 self.patientList = self.db.patients()
464 self.studyList =
self.db.studiesForPatient(self.patientList[patientNumber])
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465 self.seriesList = self.db.seriesForStudy(self.studyList[0])
466 self.fileList = self.db.filesForSeries(self.seriesList[0])
467 sliceThickness = float(self.db.fileValue(self.fileList[0], ’0018,0050’))
468 sliceSpacing = float(self.db.fileValue(self.fileList[0], ’0018,0050’))
469
470 # sliceSpacing = float(self.db.fileValue(self.fileList[0], ’0018,0088’))
471 return sliceThickness, sliceSpacing
472
473 def currentSliceInViewers(self, color):
474 """Get current slice in <color> view in RAS coordinate. In Slicer
colors represent the different views:
475 axial (red), sagittal (yellow) and coronal (green)
476 """
477 lm = slicer.app.layoutManager()
478 sw = lm.sliceWidget(color)
479 sl = sw.sliceLogic()
480 current_slice = sl.GetSliceOffset()
481 return current_slice
482
483 def convertRedSliceToIjk(self, inputVolume, sliceRAS):
484 """Convert a slice number given in RAS coordinate into slice number in
IJK coordinates
485 """
486 current_slice_RAS = sliceRAS
487 rasToIjkMatrix = vtk.vtkMatrix4x4()
488 inputVolume.GetRASToIJKMatrix(rasToIjkMatrix)
489 current_sliceIJK = rasToIjkMatrix.MultiplyPoint([1, 1,
current_slice_RAS, 1])[2]
490 return current_sliceIJK
491
492 def convertPointToIjk(self, inputVolume, point_ras):
493 # Convert a point in ras coordinates into ijk coordinates
494 point_ras_coord = point_ras[:]
495 point_ras_coord.append(1)
496 rasToIjkMatrix = vtk.vtkMatrix4x4()
497 inputVolume.GetRASToIJKMatrix(rasToIjkMatrix)
498 point_ijk_coord = rasToIjkMatrix.MultiplyPoint(point_ras_coord)
499 return point_ijk_coord[0:3]
500
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501 def transformPoint(self, transf_matrix, point):
502 """Transform point to new coordinate system given transformation matrix
503 """
504 temp_point = point
505 temp_point.append(1)
506 transf_point = transf_matrix.MultiplyPoint(temp_point)
507 return transf_point[0:3]
508
509 def MIPreset(self):
510 """ Reset slice viewers to default setting (no MIP).
511 """
512 print "Disabling MIP in the slice viewers"
513 sliceNode = None
514 sliceLogic = None
515 for slice_color in ["Green", "Red", "Yellow"]:
516 vtkMRMLSliceNode = ’vtkMRMLSliceNode’ + slice_color
517 sliceNode = slicer.mrmlScene.GetNodeByID(vtkMRMLSliceNode)
518 if sliceNode:
519 appLogic = slicer.app.applicationLogic()
520 if appLogic:
521 sliceLogic = appLogic.GetSliceLogic(sliceNode)
522 if not sliceNode or not sliceLogic:
523 print "Something is wrong, sliceNode or sliceLogic not found"
524 return
525 sliceLayerLogic = sliceLogic.GetBackgroundLayer()
526 reslice = sliceLayerLogic.GetReslice()
527 reslice.SetSlabModeToMax()
528 reslice.SetSlabNumberOfSlices(1)
529 reslice.SetSlabSliceSpacingFraction(1)
530 sliceNode.Modified()
531 return
532
533 def showMIPRed(self, inputVolume, slabThickness, slabSliceSpacingFraction,
patientNumber):
534 """ Show maximum intensity projection in the 3 slice viewers. Does not
change scalar volume, only modifies
535 viewing settings.
536 """
537
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538 print "\nShowing MIP in the axial view"
539 sliceNode = None
540 sliceLogic = None
541
542 vtkMRMLSliceNode = ’vtkMRMLSliceNodeRed’
543 sliceNode = slicer.mrmlScene.GetNodeByID(vtkMRMLSliceNode)
544 if sliceNode:
545 appLogic = slicer.app.applicationLogic()
546 if appLogic:
547 sliceLogic = appLogic.GetSliceLogic(sliceNode)
548 if not sliceNode or not sliceLogic:
549 print "Something is wrong, sliceNode or sliceLogic not found"
550 return
551 sliceThickness, sliceSpacing =
self.getSliceThicknessAndSpacing(patientNumber)
552 n_of_slices = int((slabThickness - sliceThickness) / sliceSpacing + 1)
553 spacing_fraction = slabSliceSpacingFraction
554 print "Slice thickness = ", sliceThickness, "mm"
555 print "Slice spacing = ", sliceSpacing, "mm"
556 print "Number of slices in MIP = ", n_of_slices
557 print "Actual slab thickness = ", sliceSpacing * (n_of_slices - 1) +
sliceThickness, "mm \n"
558 sliceLayerLogic = sliceLogic.GetBackgroundLayer()
559 self.reslice = sliceLayerLogic.GetReslice()
560 self.reslice.SetSlabModeToMax()
561 self.reslice.SetSlabNumberOfSlices(n_of_slices)
562 self.reslice.SetSlabSliceSpacingFraction(spacing_fraction)
563 sliceNode.Modified()
564 return
565
566 def showMIPYellow(self, inputVolume, slabThickness,
slabSliceSpacingFraction, patientNumber):
567 """ Show maximum intensity projection in the 3 slice viewers. Does not
change scalar volume, only modifies
568 viewing settings.
569 """
570
571 print "\nShowing MIP in the sagittal view"
572 sliceNode = None
94
573 sliceLogic = None
574
575 vtkMRMLSliceNode = ’vtkMRMLSliceNodeYellow’
576 sliceNode = slicer.mrmlScene.GetNodeByID(vtkMRMLSliceNode)
577 if sliceNode:
578 appLogic = slicer.app.applicationLogic()
579 if appLogic:
580 sliceLogic = appLogic.GetSliceLogic(sliceNode)
581 if not sliceNode or not sliceLogic:
582 print "Something is wrong, sliceNode or sliceLogic not found"
583 return
584 sliceThickness, sliceSpacing =
self.getSliceThicknessAndSpacing(patientNumber)
585 n_of_slices = int((slabThickness - sliceThickness) / sliceSpacing + 1)
586 spacing_fraction = slabSliceSpacingFraction
587 print "Slice thickness = ", sliceThickness, "mm"
588 print "Slice spacing = ", sliceSpacing, "mm"
589 print "Number of slices in MIP = ", n_of_slices
590 print "Actual slab thickness = ", sliceSpacing * (n_of_slices - 1) +
sliceThickness, "mm \n"
591 sliceLayerLogic = sliceLogic.GetBackgroundLayer()
592 self.reslice = sliceLayerLogic.GetReslice()
593 self.reslice.SetSlabModeToMax()
594 self.reslice.SetSlabNumberOfSlices(n_of_slices)
595 self.reslice.SetSlabSliceSpacingFraction(spacing_fraction)
596 sliceNode.Modified()
597 return
598
599 def showMIPGreen(self, inputVolume, slabThickness,
slabSliceSpacingFraction, patientNumber):
600 """ Show maximum intensity projection in the 3 slice viewers. Does not
change scalar volume, only modifies
601 viewing settings.
602 """
603
604 print "\nShowing MIP in the coronal view"
605 sliceNode = None
606 sliceLogic = None
607
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608 vtkMRMLSliceNode = ’vtkMRMLSliceNodeGreen’
609 sliceNode = slicer.mrmlScene.GetNodeByID(vtkMRMLSliceNode)
610 if sliceNode:
611 appLogic = slicer.app.applicationLogic()
612 if appLogic:
613 sliceLogic = appLogic.GetSliceLogic(sliceNode)
614 if not sliceNode or not sliceLogic:
615 print "Something is wrong, sliceNode or sliceLogic not found"
616 return
617 sliceThickness, sliceSpacing =
self.getSliceThicknessAndSpacing(patientNumber)
618 n_of_slices = int((slabThickness - sliceThickness) / sliceSpacing + 1)
619 spacing_fraction = slabSliceSpacingFraction
620 print "Slice thickness = ", sliceThickness, "mm"
621 print "Slice spacing = ", sliceSpacing, "mm"
622 print "Number of slices in MIP = ", n_of_slices
623 print "Actual slab thickness = ", sliceSpacing * (n_of_slices - 1) +
sliceThickness, "mm \n"
624 sliceLayerLogic = sliceLogic.GetBackgroundLayer()
625 self.reslice = sliceLayerLogic.GetReslice()
626 self.reslice.SetSlabModeToMax()
627 self.reslice.SetSlabNumberOfSlices(n_of_slices)
628 self.reslice.SetSlabSliceSpacingFraction(spacing_fraction)
629 sliceNode.Modified()
630 return
631
632 def windowSettings(self, inputVolume, windowWidth, windowLevel):
633 nodeID = inputVolume.GetID()
634 volumeNode = slicer.util.getNode(nodeID)
635 displayNode = volumeNode.GetDisplayNode()
636 displayNode.AutoWindowLevelOff()
637 displayNode.SetWindowLevel(windowWidth, windowLevel)
638
639 def getWindowSettings(self):
640 appLogic = slicer.app.applicationLogic()
641 sliceNode = slicer.mrmlScene.GetNodeByID(’vtkMRMLSliceNodeRed’)
642 sliceLogic = appLogic.GetSliceLogic(sliceNode)
643 window = vtk.mutable(0.0)
644 level = vtk.mutable(0.0)
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645 high = vtk.mutable (0.0)
646 low = vtk.mutable(0.0)
647 sliceLogic.GetBackgroundWindowLevelAndRange(window, level, low, high)
648 print "Window = ", window
649 print "Level = ", level
650
651 def listFiducials(self, inputVolume):
652 fidList = slicer.util.getNode(’F’)
653 numFids = fidList.GetNumberOfFiducials()
654 for i in range(numFids):
655 ras = [0, 0, 0]
656 fidList.GetNthFiducialPosition(i, ras)
657 print "Fid", i+1, ": RAS = ", ras, ", label = ",
fidList.GetNthFiducialLabel(i)
658 return
659
660 def getPhase(self, inputVolume, patientNumber, p1, p2, p3, p4, p5, radius):
661 segmentationNode = slicer.vtkMRMLSegmentationNode()
662 slicer.mrmlScene.AddNode(segmentationNode)
663 segmentationNode.CreateDefaultDisplayNodes()
664 segmentationNode.SetReferenceImageGeometryParameterFromVolumeNode(
665 inputVolume)
666
667 fidList = slicer.util.getNode(’F’)
668
669 # For scans where superior sagittal sinus is out of scanned volume
670 if p5 == -1:
671 p = [p1, p2, p3, p4]
672 colours = ([1.0, 0.0, 0.0], [1.0, 0.5, 1.0], [0.0, 1.0, 0.0], [0.0,
0.0, 1.0])
673 segm_names = (’ICA’, ’MCA-M1’, ’SIGMOID’, ’TORCULA’)
674 else:
675 p = [p1, p2, p3, p4, p5]
676 colours = ([1.0, 0.0, 0.0], [1.0, 0.5, 1.0], [0.0, 1.0, 0.0], [0.0,
0.0, 1.0], [0.5, 0.0, 1.0])
677 segm_names = (’ICA’, ’MCA-M1’, ’SIGMOID’, ’TORCULA’, ’SUP SAG
SINUS’)
678
679 p_append = vtk.vtkAppendPolyData()
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680 p_coords = []
681
682 for i in range(len(p)):
683 ras = [0, 0, 0]
684 fidList.GetNthFiducialPosition(i, ras)
685 vess_seed = vtk.vtkSphereSource()
686 vess_seed.SetCenter(ras)
687 vess_seed.SetRadius(radius)
688 vess_seed.Update()
689 p_coords.append(ras)
690
691 segmentID =
segmentationNode.AddSegmentFromClosedSurfaceRepresentation(
692 vess_seed.GetOutput(), segm_names[i], colours[i])
693
694 resultsTableNode = slicer.vtkMRMLTableNode()
695 slicer.mrmlScene.AddNode(resultsTableNode)
696
697 statLogic = SegmentStatistics.SegmentStatisticsLogic()
698 statLogic.getParameterNode().SetParameter("Segmentation",
segmentationNode.GetID())
699 statLogic.getParameterNode().SetParameter("ScalarVolume",
inputVolume.GetID())
700 statLogic.computeStatistics()
701 statLogic.exportToTable(resultsTableNode)
702 statLogic.showTable(resultsTableNode)
703 stat = statLogic.getStatistics()
704
705 del stat[’MeasurementInfo’]
706 patientID = self.getPatientID(patientNumber)
707
708
709 results_fileName = exp_folder + "phase_data.txt"
710 results_f = open(results_fileName, ’a+’)
711 pickle_fileName = exp_folder + "pickle_data_" + patientID
712 pickle_f = open(pickle_fileName, ’wb+’)
713 export_data = {}
714 header = ’PatientID’
715 lines = patientID
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716
717 for segmID in segm_names:
718 segment_data = {
719 segmID + ’_ras’ : p_coords[segm_names.index(segmID)],
720 segmID + ’_closedSurface_surf_mm2’ : stat[(segmID,
’ClosedSurfaceSegmentStatisticsPlugin.surface_mm2’)],
721 segmID + ’_closedSurface_vol_mm3’ : stat[(segmID,
’ClosedSurfaceSegmentStatisticsPlugin.volume_mm3’)],
722 segmID + ’_labelMap_volume_mm3’ : stat[(segmID,
’LabelmapSegmentStatisticsPlugin.volume_mm3’)],
723 segmID + ’_labelMap_voxelcount’ : stat[(segmID,
’LabelmapSegmentStatisticsPlugin.voxel_count’)],
724 segmID + ’_scalarVolume_max’ : stat[(segmID,
’ScalarVolumeSegmentStatisticsPlugin.max’)],
725 segmID + ’_scarVolume_min’ : stat[(segmID,
’ScalarVolumeSegmentStatisticsPlugin.min’)],
726 segmID + ’_scalarVolume_mean’ : stat[(segmID,
’ScalarVolumeSegmentStatisticsPlugin.mean’)],
727 segmID + ’_scalarVolume_stdev’ : stat[(segmID,
’ScalarVolumeSegmentStatisticsPlugin.stdev’)],
728 segmID + ’_scalarVolume_vol_mm3’ : stat[(segmID,
’ScalarVolumeSegmentStatisticsPlugin.volume_mm3’)],
729 segmID + ’_scalarVolume_voxelcount’ : stat[(segmID,
’ScalarVolumeSegmentStatisticsPlugin.voxel_count’)]
730 }
731 export_data[segmID] = segment_data
732
733 keys = [segmID + ’_ras’,
734 segmID + ’_closedSurface_surf_mm2’,
735 segmID + ’_closedSurface_vol_mm3’,
736 segmID + ’_labelMap_volume_mm3’,
737 segmID + ’_labelMap_voxelcount’,
738 segmID + ’_scalarVolume_max’,
739 segmID + ’_scarVolume_min’,
740 segmID + ’_scalarVolume_mean’,
741 segmID + ’_scalarVolume_stdev’,
742 segmID + ’_scalarVolume_vol_mm3’,
743 segmID + ’_scalarVolume_voxelcount’]
744
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745 values = [segment_data[segmID + ’_ras’]]
746
747 for i in keys[1:]:
748 values.append(’%.5f’ % segment_data[i])
749
750 header += ’\t’ + ’\t’.join(keys)
751 lines += ’\t’ + str(values[0]) + ’\t’ + ’\t’.join(values[1:])
752
753 pprint (export_data)
754 pkl.dump(export_data, pickle_f)
755 pickle_f.close()
756
757 # results_f.seek(0)
758 # if (results_f.readline()==""):
759 # results_f.write(header + ’\n’)
760 results_f.write(lines + ’\n’)
761
762 results_f.close()
763
764 return
765
766 #
767 # Slicer modules standard test code
768 #
769 class CTA_phaseTest(ScriptedLoadableModuleTest):
770 """ Tests"""
771
772 def setUp(self):
773 """ Do whatever is needed to reset the state - typically a scene clear
will be enough.
774 """
775 slicer.mrmlScene.Clear(0)
776 sliceNode = None
777 sliceLogic = None
778
779 for slice_color in ["Green", "Red", "Yellow"]:
780 vtkMRMLSliceNode = ’vtkMRMLSliceNode’ + slice_color
781 sliceNode = slicer.mrmlScene.GetNodeByID(vtkMRMLSliceNode)
782
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783 if sliceNode:
784 appLogic = slicer.app.applicationLogic()
785 if appLogic:
786 sliceLogic = appLogic.GetSliceLogic(sliceNode)
787
788 if not sliceNode or not sliceLogic:
789 print "Something is wrong, sliceNode or sliceLogic not found"
790 return
791
792 sliceLayerLogic = sliceLogic.GetBackgroundLayer()
793 reslice = sliceLayerLogic.GetReslice()
794 reslice.SetSlabModeToMax()
795 reslice.SetSlabNumberOfSlices(1)
796 reslice.SetSlabSliceSpacingFraction(1)
797 sliceNode.Modified()
798
799 def runTest(self):
800 self.delayDisplay("Starting the test")
801 self.setUp()
802 self.test_CTA_phase1()
803 self.delayDisplay(’Test passed!’)
804
805 def test_CTA_phase1(self):
806 import urllib
807 downloads = (
808 (’http://slicer.kitware.com/midas3/download?items=5767’, ’FA.nrrd’,
slicer.util.loadVolume),
809 )
810
811 for url,name,loader in downloads:
812 filePath = slicer.app.temporaryPath + ’/’ + name
813 if not os.path.exists(filePath) or os.stat(filePath).st_size == 0:
814 logging.info(’Requesting download %s from %s...\n’ % (name, url))
815 urllib.urlretrieve(url, filePath)
816 if loader:
817 logging.info(’Loading %s...’ % (name,))
818 loader(filePath)
819 self.delayDisplay(’Finished with download and loading’)
820
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821 volumeNode = slicer.util.getNode(pattern="FA")
822
823 return
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